Category: Alternative Medicine

  • 8 Amazing Benefits of Astragalus Root According to Scientific Studies

    8 Amazing Benefits of Astragalus Root According to Scientific Studies

    Astragalus Root

    Astragalus is a plant in the legume family, native to Asia. Its root has been used in traditional Chinese medicine for centuries as an immune system booster and to prevent and treat various illnesses. It is also known as Huang Qi in Chinese traditional medicine. Astragalus supplements are available in various forms, including capsules, teas, and tinctures.

    Astragalus is a flowering plant native to China and Korea. In traditional Chinese medicine (TCM), the root of the astragalus plant is used as a tonic and adaptogen. The root is sliced and dried, then it’s ground into a powder, steeped as tea, or even added to the stock in stews. Research today finds that it stimulates the immune system and promotes homeostasis in the body. Here are 8 impressive benefits, according to scientific reports:

    1. Lowers Stress Levels

    In Chinese medicine, astragalus is associated with the “earth” element. It’s considered an adaptogen because it promotes homeostasis in response to stressors and helps the body adapt to stress.

    To test the effect of astragalus on stress hormones, scientists in one study looked at milk-producing cows under heat stress. Heat exposure normally reduces milk production in cows, but astragalus intervention was shown to mitigate this effect by lowering cortisol — the main hormone responsible for producing a stress response in the body.[1]

    In a study on mice, astragalus was shown to counter the mental and behavioral impairments caused by stress. The mice given astragalus performed better on mazes, which scientists translate to better spatial memory, learning, and anxiety levels.[2]

    2. Helps Normalize Blood Sugar Levels

    In an analysis of 13 studies on the effects of astragalus on people with type 2 diabetes, astragalus was reported to lower high blood sugar when taken daily at a dose of around 50 mg.[3] Astralagus root is a staple anti-diabetic herb prescribed in traditional Chinese medicine, and modern studies have identified various plant compounds like flavonoids and polysaccharides in astragalus that are responsible for its effects on blood sugar. These medicinal molecules improve insulin sensitivity, helping to regulate and normalize blood glucose levels.[4]

    3. Supports Cardiovascular Health

    Atherosclerosis is the hardening of the arteries and buildup of plaque that can put you at risk of a heart attack. In a study published in Oxidative Medicine and Cellular Longevity, researchers attributed antioxidants in astragalus to its ability to reverse atherosclerosis in rabbits. In the study, rabbits given astragalus had lower cholesterol levels and blood pressure, indicating a reduced risk for heart disease after just 12 weeks.[5]

    Research on the effects of astragalus on heart disease patients is lacking. However, animal trials suggest astragalus has heart-protective benefits that could assist in preventing cardiovascular disease.

    4. Fights Cancer

    In human trials, astragalus has been found to increase the anti-tumor effects of chemotherapy. In fact, astragalus can shrink tumors and prevent cancer from spreading to other parts of the body.[6] Lab studies show that astragalus has anti-cancer effects against human lung cancer, breast cancer, and colon cancer.[7,8,9] One of the ways astragalus works is by enhancing the immune system’s natural defense against cancer cell growth. The antioxidants in astragalus may also help with cancer prevention by protecting cells and organs against oxidative damage.

    5. May Counter Chemotherapy Side Effects

    In addition to defending the body against cancer, astragalus could also help in reducing the side effects of chemotherapy drugs. According to a review of multiple studies on patients undergoing chemotherapy, astragalus root effectively reduces nausea and vomiting compared to a placebo.[10]

    6. Boosts Your Immune System

    As an adaptogen, astragalus can stimulate a depressed or burdened immune system. Chronic stress, as well as consuming large amounts of caffeine, sugar, or alcohol, can suppress immune function and make you more vulnerable to colds, flu, and other infections. Astragalus root seems to jumpstart the various immune cells and their functions, causing white blood cells to circulate in the body and mitigate threats more effectively.[11] While more research is needed, it’s possible that supplementing with astragalus could help protect against common colds by strengthening immune function.

    7. Supports Kidney Health

    One of the traditional uses of astragalus in Chinese medicine is to support kidney health. Astragalus root has been found to improve proteinuria, which is the presence of too much protein in the urine. Chronic kidney disease is characterized by kidney damage affecting the ability of the kidneys to filter waste. In a study on patients with chronic kidney disease, astragalus root supplementation was found to improve kidney function.[12]

    8. Protects Brain Health

    Amyloid beta is the toxic waste responsible for Alzheimer’s and dementia when it builds up in the brain. In a study on rats injected with amyloid beta, a group of rats also injected with astragalus root were found to have less neurological damage and symptoms of anxiety compared to the control group. While human studies are needed, it’s possible that astragalus could help in the prevention of neurodegeneration.[13]

    Astragalus Root Safety

    Side effects with astragalus root are rare. Potential side effects that can occur are itching, rash, and gastrointestinal discomfort. Not enough is known about the effects of astragalus on pregnant and breastfeeding mothers, who should therefore avoid it.[14] People with an autoimmune disease should approach astragalus with caution because it can stimulate activity in the immune system.

    Astragalus Benefits and Uses

    There are many reasons astragalus root has been revered in TCM for centuries. It can help protect against diseases like diabetes, cancer, heart disease, and even neurological disease like Alzheimer’s and dementia. As an adaptogen, astragalus can help you beat stress and boost your immune system. Astragalus root is found as a tincture, tea, or in capsule form.

    Please note that it is important to consult a healthcare professional before taking any supplement, especially if you have a medical condition or are taking any medications.

    References:

    1. “Analysis of Astragalus Polysaccharide Intervention in Heat-Stressed Dairy Cows’ Serum Metabolomics” by Hanfang Zeng, Yumeng Xi, Yeqing Li, Zedong Wang, Lin Zhang and Zhaoyu Han, 29 March 2020, Animals.
      DOI: 10.3390/ani10040574
    2. “The Effects of Astragalus Membranaceus on Repeated Restraint Stress-induced Biochemical and Behavioral Responses” by Hyun-Jung Park, Hyun Young Kim, Kun-Ho Yoon, Kyung Soo Kim and Insop Shim, 17 August 2009, The Korean Journal of Physiology & Pharmacology.
      DOI: 10.4196/kjpp.2009.13.4.315
    3. “The effect of Astragalus as an adjuvant treatment in type 2 diabetes mellitus: A (preliminary) meta-analysis” by Huiping Tian, Jun Lu, Hairong He, Lu Zhang, Yalin Dong, Hongping Yao, Weiyi Feng and Siwen Wang, 3 June 2016, Journal of Ethnopharmacology.
      DOI: 10.1016/j.jep.2016.05.062
    4. “Recent Advances in Astragalus membranaceus Anti-Diabetic Research: Pharmacological Effects of Its Phytochemical Constituents” by Kojo Agyemang, Lifeng Han, Erwei Liu, Yi Zhang, Tao Wang and Xiumei Gao, 17 November 2013, Evidence-Based Medicinal Plants for Modern Chronic Diseases.
      DOI: 10.1155/2013/654643
    5. “Study of the Effects of Total Flavonoids of Astragalus on Atherosclerosis Formation and Potential Mechanisms” by Deqing Wang, Yuan Zhuang, Yaping Tian, Graham Neil Thomas, Mingzhong Ying and Brian Tomlinson, 29 January 2012, Oxidative Medicine and Cellular Longevity.
      DOI: 10.1155/2012/282383
    6. “Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: Status and prospect” by Shanshan Li, Yi Sun, Jin Huang, Bin Wang, Yinan Gong, Yuxin Fang, Yangyang Liu, Shenjun Wang, Yi Guo, Hong Wang, Zhifang Xu and Yongming Guo, 1 April 2020, Journal of Ethnopharmacology.
      DOI: 10.1016/j.jep.2020.112797
    7. “Anticancer activity of Astragalus polysaccharide in human non-small cell lung cancer cells” by Chao-Yan Wu, Yuan Ke, Yi-Fei Zeng, Ying-Wen Zhang and Hai-Jun Yu, 4 December 2017, Cancer Cell International.
      DOI: 10.1186/s12935-017-0487-6
    8. “Anti-tumor potential of astragalus polysaccharides on breast cancer cell line mediated by macrophage activation” by Wenfang Li, Kedong Song, Shuping Wang, Chenghong Zhang, Meiling Zhuang, Yiwei Wang and Tianqing Liu, 8 January 2019, Materials Science and Engineering: C.
      DOI: 10.1016/j.msec.2019.01.025
    9. “Astragalus saponins modulates colon cancer development by regulating calpain-mediated glucose-regulated protein expression” by Yue Wang, Kathy K Auyeung, Xiaoyu Zhang and Joshua K Ko, 15 October 2014, BMC Complementary and Alternative Medicine.
      DOI: 10.1186/1472-6882-14-401
    10. “Integrative Medicine for Relief of Nausea and Vomiting in the Treatment of Colorectal Cancer Using Oxaliplatin-Based Chemotherapy: A Systematic Review and Meta-Analysis” by Meng hua Chen, Brian H. May, Iris W. Zhou, Anthony L. Zhang and Charlie C. Xue, 23 February 2016, Phytotherapy Research.
      DOI: 10.1002/ptr.5586
    11. Astragalus membranaceus Extract Activates Immune Response in Macrophages via Heparanase” by Qiaojing Qin, Jianying Niu, Zhaoxia Wang, Wangjie Xu, Zhongdong Qiao and Yong Gu, 13 June 2012, Molecules.
      DOI: 10.3390/molecules17067232
    12. “Oral Astragalus Root Supplementation for Mild to Moderate Chronic Kidney Disease: A Self-Controlled Case-Series” by Tetsuhiro Yoshino, Yuko Horiba, Masaru Mimura and Kenji Watanabe, 1 March 2022, Frontiers in Pharmacology.
      DOI: 10.3389/fphar.2022.775798
    13. “Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the Aβ-injected rat” by Z. Bahaeddin, A. Yans, F. Khodagholi and S. Sahranavard, October 2016, Research Journal of Pharmacognosy.
    14. https://www.nccih.nih.gov/health/astragalus

    This is a general information article and should not be taken as professional medical advice. Always consult with a qualified healthcare professional before taking any herbal supplement or making any changes to your diet or exercise routine. Herbal supplements can interact with certain medications and may not be safe for everyone. Some supplements may not have been adequately tested for safety or effectiveness, and their claims may not have been evaluated by the FDA. Additionally, the dosage and purity of supplements can vary between brands, so it is important to purchase supplements from a reputable source. Keep in mind that the use of herbal supplements is not intended to diagnose, treat, cure or prevent any disease or medical condition.

  • Chinese medicine expert reveals NATURAL alternative to weight loss drug Ozempic

    Chinese medicine expert reveals NATURAL alternative to weight loss drug Ozempic

    A traditional Chinese medicine expert has offered up what she says is a natural alternative to weight loss drug Ozempic, while claiming that the centuries-old remedy has ‘no negative side effects’. 

    The Eastern Philosophy, an Asian-owned small business that specializes in herbal medicines, frequently shares educational videos about health on TikTok, including a recent video that has showcased Hawthorn Combo supplements, which are said to reduce fat and be an ‘approved treatment in Germany for heart failure.’ 

    In a video, which has amassed over 15,000 views, the small business owner suggested the herb was a ‘delicious’ alternative to the drug, adding that it significantly helps to reduce ‘body weight and fat build-up.’ 

    Chinese medicine expert reveals NATURAL alternative to weight loss drug Ozempic

    The Eastern Philosophy has offered up a natural alternative to weight loss drug Ozempic, which she claims has ‘no negative side effects’

    The small business owner that the natural alternative is said to promote better heart health and digestion

    The small business owner that the natural alternative is said to promote better heart health and digestion

    The small business owner that the natural alternative is said to promote better heart health and digestion

    Ozempic is a type 2 diabetes treatment that is used off-label as a weight loss drug

    Ozempic is a type 2 diabetes treatment that is used off-label as a weight loss drug

    A natural alternative to Ozempic? The Eastern Philosophy’s remedy that has no negative side effects 

    • Hawthorn is said to be an alternative to the type 2 diabetes drug that melts away fat
    • The small business owner said that Hawthorn has ‘no negative side effects’ 
    • She noted that the natural alternative is said to promote better heart health and digestion 
    • The small business owner added that is has been approved as a treatment in Germany for heart failure 

    ‘If you want a natural alternative to Ozempic, check out this herb. It’s been shown in studies to reduce fat, body weight, and cholesterol, and it has several thousand years of use in traditional Chinese medicine,’ the owner said before adding that it was also known as ‘Shanzha’ and ‘Crataegus.’ 

    She went on to explain that one study dubbed it a ‘miracle herb and an anti-obesity agent.’ 

    The small business owner said another study claimed that those who consumed Hawthorn extract had ‘significantly lower body weights and decreased adipose tissue.’ 

    And unlike the weight loss drug – which is known to have many side effects including low blood sugar, upset stomachs, heartburn, burping, gas, bloating, nausea, vomiting, stomach pain, loss of appetite, diarrhea, constipation, stomach flu symptoms, headaches, dizziness, tiredness – she said this herb ‘has no negative side effects’ and instead, has ‘positive side effects.’ 

    The owner of The Eastern Philosophy explained that the natural alternative helps promote ‘better heart health and digestion.’ 

    She added that it is an ‘approved treatment in Germany for stage II heart failure.’ 

    And if you have ever had Hawthron candy and may be excited to satisfy your sweet tooth while reducing your body weight, the small business owner noted that while delicious, Hawthorn candy is ‘not medicinal.’ 

    She explained that it significantly helps to reduce body fat when not in its candy form

    She explained that it significantly helps to reduce body fat when not in its candy form

    She explained that it significantly helps to reduce body fat, but not when it is in its candy form 

    The small business owner added that is has been approved as a treatment in Germany for heart failure

    The small business owner added that is has been approved as a treatment in Germany for heart failure

    The small business owner added that is has been approved as a treatment in Germany for heart failure

    @easternphilosophy

    A weight loss herb that’s also an approved treatment for heart failure in Germany! We stock hawthorn extract on our site under Hawthorn Combo 🍒 One of the most popular street foods in China is Tang Hulu—hawthorn dipped in liquid sugar which hardens into a crunchy candy shell. Recently, I was able to get my hands on fresh hawthorn for the first time ever in the US and made some improvised Tang Hulu and hawthorn paste—don’t make it this way as it didn’t turn out pretty! This tangy fruit is not only delicious—it also has fat-burning, cholesterol lowering, blood sugar-lowering, and heart-strengthening properties. Hawthorn is a popular snack, but it’s also a well-known herb in traditional Chinese medicine and increasingly in Western medicine. Studies show that in animals fed high-fat diets, hawthorn extract significantly reduced body weight and fat build-up. Sugar taken from hawthorn also promoted the growth of obesity-fighting gut bacteria, suggesting its potential as a weight-loss prebiotic. Hawthorn is also used in Western medicine for heart failure, chest pain, and irregular heartbeat—in Germany, hawthorn extract is an approved prescription medication for chronic heart failure. It is also used to treat both low blood pressure and high blood pressure, hardening of the arteries (atherosclerosis), and high cholesterol. Studies also show that hawthorn can increase coronary artery blood flow and improve circulation. It’s also considered one of the best herbs for grief. A review of 29 studies comprising more than 5,500 people found that hawthorn was safe and had no side effects. Hawthorn is one of our best-selling supplements and we just sold out of our single-herb Hawthorn Extract! Our popular Hawthorn Combo is in stock, which is made in USA and contains hawthorn extract, as well as prized herbs including He Shou Wu (anti-aging, hair growing) and San Qi (improve circulation and cardiovascular health). While hawthorn candies and snacks are delicious, they are not considered medicinal due to their high sugar content. . . . #holistichealth #chinesemedicine #tcm #herbalmedicine #weightloss #fatloss #weightlossjourney #hearthealth #asianfood #chinesecooking #tanghulu #ozempic

    ♬ Heart It Races – Architecture In Helsinki

    According to the owner, the best way to reap the benefits of the herb is by taking a Hawthorn extract supplement. 

    The company sells the supplement on its website for just $10.25. 

    Both Ozempic and its sister drug Wegovy have been hailed as magic bullets for obesity and their ability to melt fat away within a matter of weeks. 

    Ozempic was first approved by the FDA as a medication for type 2 diabetes in 2017, while Wegovy was approved by the FDA as a weight management treatment in 2021. 

    The drugs have taken the world by storm since they came out, with both celebrities and patients gushing over its ability to decrease fat. 

    Everyone from Hollywood stars to tech moguls are turning to the injectable drug to stay slim, with Elon Musk (seen in August 2022) crediting the drug in October for his recent weight loss

    Everyone from Hollywood stars to tech moguls are turning to the injectable drug to stay slim, with Elon Musk (seen in August 2022) crediting the drug in October for his recent weight loss

    Influencer Remi Bader has detailed how she gained 'double the weight back' and grappled with binge eating again after getting off the 'trendy' new diet drug

    Influencer Remi Bader has detailed how she gained ‘double the weight back’ and grappled with binge eating again after getting off the ‘trendy’ new diet drug

    Ozempic: The diabetes drug turned weight loss phenomenon 

    Ozempic is a type 2 diabetes and pre-diabetes drug that uses the active ingredient semaglutide.

    It is also popularly used off-label because of its strong weight loss properties.

    It is to be injected into a person’s, arm, thigh or stomach to help regulate their blood sugar and suppress appetite. 

    The drug has reportedly become popular among celebrities because of its intense weight loss effects.

    It is a GLP-1 receptor that causes the pancreas to release insulin – the hormone responsible for regulating blood sugar.

    The drug also slows down food exiting the stomach, decreasing a person’s appetite. 

    Studies have found that GLP-1s are highly affective weight loss tools.

    In a 2021 study, patients who used  semaglutide dropped 14 per cent of their weight over a 68 week period, compared to only two per cent weight loss among those who used a placebo

    It’s injected into the stomach, thigh or arm and helps to suppress a person’s appetite – making it an an easy and quick solution to weight loss. 

    Ozempic has been approved by the Food and Drug Administration for type two diabetes treatment, which means its use as a weight loss drug is off-label. 

    The treatment totals around $950 a month, but since its weight loss effects are off-label, insurance is unlikely to cover the cost. 

    Despite the price, the treatment has gained extreme popularity causing the FDA adding both Ozempic and Wegovy to its drug shortage list, making it more difficult for those struggling with diabetes to receive treatment. 

    Celebrities have also gushed over the drug, with tech mogul Elon Musk crediting the miracle fat-burning bullet for his body transformation and actor Jeremy Clarkson also claiming he used the drug. 

    TikTok star Remi Bader, 27, has been transparent about her use with the drug and detailed how she ‘gained double the weight’ and struggled with binge eating  after stopping the treatment. 

    She described her struggles getting off the medication after a doctor instructed her to begin taking it for ‘actual health issues’ in an interview with Amanda Hirsch on the Not Skinny But Not Fat podcast.

    Bader, who sought treatment for binge eating disorder last year, claimed her binging ‘got so much worse’ after she stopped taking the diabetes drug Ozempic.

    And since the drug has seen so many shortages, celebrities are dropping as much as $1,500 a month on the fat-buster, making it near impossible for those to receive the treatment they desperately need. 

  • 3D Printing Revolutionizing the Orthopedic Splints and Casts Market with Tremendous Opportunities, the Market to Mark USD 3.34 Billion by 2027

    3D Printing Revolutionizing the Orthopedic Splints and Casts Market with Tremendous Opportunities, the Market to Mark USD 3.34 Billion by 2027

    CHICAGO, Jan. 18, 2023 /PRNewswire/ — According to Arizton’s latest research report, the global orthopedic splints and casts market will grow at a CAGR of 6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from 2021-2027. Growing demand for 3D printed casts & splints, availability of a wider product portfolio of splints & casts by vendors, and introduction of spray-based form splints are significant growth opportunities in the orthopedic splints & casts market.

    Orthopedic Splints And Casts Market

    Orthopedic Splints And Casts Market

    3D printing is an evolving technology that has a potential application in treating pediatric forearm fractures. The clinical outcomes were excellent at the latest follow-up, at least one-year post-injury. 3D-printed casts may allow for greater patient satisfaction and reduced complications in adult and pediatric patients as this technology becomes further integrated into medicine, specifically orthopedics. Orthopedic surgeons may benefit from familiarizing themselves with the potential of 3D printing technology and its current applications and devising future applications for clinical practice. Many emerging companies are developing 3D-printed splints & casts. For instance, ActiveArmour, a leading global company in 3D printed casting/splinting, designs a wholly individualized and fitted splint based on the physician’s specific positioning and instructions for each patient’s unique needs. Another company in the 3D printed splints & casts market, Fix It, designs 3D printed splints made from biodegradable plastic as an alternative to traditional casts. Thus, emerging 3D printed splints/casts products will accelerate the orthopedic splint & casts market.

    GLOBAL ORTHOPEDIC SPLINTS AND CASTS MARKET REPORT SCOPE

    Report Attributes

    Details

    Market Size (2027)

    USD 3.34 Billion

    Market Size (2021)

    USD 2.34 Billion

    CAGR (2021-2027)

    6.06 {fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Base Year

    2021

    Forecast Year

    2022-2027

    Market Segments

    Product, Material, Body Part, End User, and Geography

    Geographic Analysis

    North America, Europe, APAC, Latin America, and Middle East & Africa

    Key Leading Countries

    China, India, Japan, South Korea, Australia, Germany, Italy, Spain, France, the UK, the US, Canada, Brazil, Mexico, Argentina, Turkey, South Africa, South Arabia, Egypt, and Nigeria

    Key Prominent Players

    Essity Medical Solutions, 3M, Enovis, Breg, DeRoyal Industries, Bauerfeind, ALCARE, Frank Stubbs Company, Weber Orthopedic LP. DBA Hely & Weber, medi, Carolina Narrow Fabric, Thuasne Group, Trulife, Tynor, Orthosys, DUK-IN, Performance Health, AliMed, Lohmann & Rauscher, Elite Orthopaedics, Allard USA, BraceAbility, VISSCO REHABILITATION, Bird & Cronin, Datt Mediproducts, and Prime Medical

    Page Number

    292

    Market Dynamics

    • Increasing Target Patient Population

    • Rising Adoption of Fiberglass Casts & Splints

    • Paradigm Shift Towards Outpatient Orthopedic Care

    Customization Request

    If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3642

     

    Click Here to Download the Free Sample Report

    APAC TO OBSERVE FASTEST GROWTH IN THE ORTHOPEDIC SPLINTS AND CASTS MARKET

    APAC is leading the orthopedic splints & casts market, contributing to increased MSDs incidence, a growing aging population, and related health conditions. APAC accommodates many regional and local orthopedic splints & cast manufacturers actively developing innovative orthopedic splints & casts at affordable costs. China, Japan, Australia, India, and South Korea are major countries contributing to the exponential growth of the market in this region.

    APAC has become an appealing market for global players and expansionary private investments that can effectively support innovation while driving consumption and capitalizing on demographic and emerging consumer trends. Overall, the rapidly growing life expectancy, economic growth, and more effective treatment procedures offer long-term growth opportunities for the APAC orthopedic splints & casts market.

    Moreover, introducing innovative concepts around orthopedic medicine in the orthopedic splints and casts market can be a game changer because of several benefits over conventional orthopedic splints and casts. The emergence of the spray-based form splint is offering leading players and start-ups the opportunity to develop orthopedic splints & casts with the help of polyurethane spray.

    RECENT DEVELOPMENTS IN THE GLOBAL ORTHOPEDIC SPLINTS AND CASTS MARKET

    • In early 2019, Enovis (formulary known as Colfax) completed the acquisition of DJO for around USD 3.15 billion. With this acquisition, Colfax aimed to create a new platform for itself in the orthopedic market, as DJO was one of the leading companies in braces and support devices.

    • Breg, a leading orthopedic and billing services company, partnered with its UK distributor, Joint Operations, to expand the supply of high-quality orthopedic products to the UK/Ireland market in July 2020.

    COMPETITIVE OVERVIEW

    The orthopedic splints & casts market is pursuing various strategies to provide the impetus for growth over the next few years. These market participants adopt cooperation, partnerships, mergers & acquisitions, and product launches. Due to these strategies, the orthopedic splints & casts market has the potential to have significant growth opportunities. For instance, Breg partnered with the Australian distributor Club Warehouse to expand its supply of high-quality orthopedic products to the Australian market.

    KEY COMPANY PROFILES

    MARKET SEGMENTATION

    Product

    Material

    Body Part

    End User

    Geography

    • APAC

    • Europe

    • North America

    • Latin America

    • Middle East & Africa

    Click Here to Download the Free Sample Report

    CHECK OUT SOME OF THE TOP-SELLING RELATED RESEARCH REPORTS:

    Bone Growth Products Market – The global bone growth product market is expected to reach USD 1.4 billion in 2027.

    Orthopedic Braces and Supports Market – The orthopedic braces & supports is expected to reach USD 4.42 billion by 2027.

    Interbody Spinal Implants Market – The interbody spinal implants market is estimated to reach USD 2.1 billion by 2027.

    Medical Exoskeleton Market – The global medical exoskeleton market size is expected to reach USD 3.81 billion by 2027.

    TABLE OF CONTENT

    1 RESEARCH METHODOLOGY

    2 RESEARCH OBJECTIVES

    3 RESEARCH PROCESS

    4 SCOPE & COVERAGE

    4.1 MARKET DEFINITION

    4.1.1 INCLUSIONS

    4.1.2 EXCLUSIONS

    4.1.3 MARKET ESTIMATION CAVEATS

    4.2 BASE YEAR

    4.3 SCOPE OF THE STUDY

    4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

    5 REPORT ASSUMPTIONS & CAVEATS

    5.1 KEY CAVEATS

    5.2 CURRENCY CONVERSION

    5.3 MARKET DERIVATION

    6 MARKET AT A GLANCE

    7 PREMIUM INSIGHTS

    7.1 MARKET OVERVIEW

    7.1.1 MARKET DYNAMICS

    7.1.2 MARKET SEGMENTATION

    7.1.3 VENDOR ANALYSIS

    8 INTRODUCTION

    8.1 OVERVIEW

    8.1.1 MUSCULOSKELETAL DISORDERS STATISTICS

    9 MARKET OPPORTUNITIES & TRENDS

    9.1 GROWING DEMAND FOR 3D-PRINTED CASTS & SPLINTS

    9.2 AVAILABILITY OF WIDER PRODUCT PORTFOLIO OF SPLINTS & CASTS BY VENDOR

    9.3 INTRODUCTION OF SPRAY-BASED FORM SPLINTS

    10 MARKET GROWTH ENABLERS

    10.1 INCREASING TARGET PATIENT POPULATION

    10.2 RISING ADOPTION OF FIBERGLASS CASTS & SPLINTS

    10.3 PARADIGM SHIFT TOWARD OUTPATIENT ORTHOPEDIC CARE

    11 MARKET RESTRAINTS

    11.1 COMPLICATIONS ASSOCIATED WITH THE USE OF SPLINTS AND CASTS

    11.2ALTERNATIVE TREATMENT OPTIONS FOR ORTHOPEDIC DISORDERS & CONDITIONS

    11.3 LACK OF PRODUCT DIFFERENTIATION COUPLED WITH PRICING PRESSURE

    12 MARKET LANDSCAPE

    12.1 MARKET OVERVIEW

    12.2 MARKET SIZE & FORECAST

    12.2.1 INSIGHT BY PRODUCT SEGMENTATION

    12.2.2 INSIGHT BY MATERIAL SEGMENTATION

    12.2.3 INSIGHT BY BODY PART SEGMENTATION

    12.2.4 INSIGHT BY END-USERS SEGMENTATION

    12.2.5 INSIGHT BY GEOGRAPHY SEGMENTATION

    12.3 FIVE FORCES ANALYSIS

    12.3.1 THREAT OF NEW ENTRANTS

    12.3.2 BARGAINING POWER OF SUPPLIERS

    12.3.3 BARGAINING POWER OF BUYERS

    12.3.4 THREAT OF SUBSTITUTES

    12.3.5 COMPETITIVE RIVALRY

    13 PRODUCT

    13.1 MARKET SNAPSHOT & GROWTH ENGINE

    13.2 MARKET OVERVIEW

    13.3 CASTS

    13.3.1 MARKET OVERVIEW

    13.3.2 MARKET SIZE & FORECAST

    13.3.3 MARKET BY GEOGRAPHY

    13.4 SPLINT

    13.4.1 MARKET OVERVIEW

    13.4.2 MARKET SIZE & FORECAST

    13.4.3 MARKET BY GEOGRAPHY

    14 MATERIALS

    14.1 MARKET SNAPSHOT & GROWTH ENGINE

    14.2 MARKET OVERVIEW

    14.3 SYNTHETIC SPLINTS & CASTS

    14.3.1 MARKET OVERVIEW

    14.3.2 MARKET SIZE & FORECAST

    14.3.3 MARKET BY GEOGRAPHY

    14.4 PLASTER OF PARIS SPLINTS & CASTS

    14.4.1 MARKET OVERVIEW

    14.4.2 MARKET SIZE & FORECAST

    14.4.3 MARKET BY GEOGRAPHY

    15 BODY PART

    15.1 MARKET SNAPSHOT & GROWTH ENGINE

    15.2 MARKET OVERVIEW

    15.3 UPPER BODY

    15.3.1 MARKET OVERVIEW

    15.3.2 MARKET SIZE & FORECAST

    15.3.3 MARKET BY GEOGRAPHY

    15.4 LOWER BODY

    15.4.1 MARKET OVERVIEW

    15.4.2 MARKET SIZE & FORECAST

    15.4.3 MARKET BY GEOGRAPHY

    16 END-USER

    16.1 MARKET SNAPSHOT & GROWTH ENGINE

    16.2 MARKET OVERVIEW

    16.3 ORTHOTIC & ORTHOPEDIC CLINICS

    16.3.1 MARKET OVERVIEW

    16.3.2 MARKET SIZE & FORECAST

    16.3.3 MARKET BY GEOGRAPHY

    16.4 HOSPITAL

    16.4.1 MARKET OVERVIEW

    16.4.2 MARKET SIZE & FORECAST

    16.4.3 MARKET BY GEOGRAPHY

    16.5 OTHERS

    16.5.1 MARKET OVERVIEW

    16.5.2 MARKET SIZE & FORECAST

    16.5.3 MARKET BY GEOGRAPHY

    17 GEOGRAPHY

    17.1 MARKET SNAPSHOT & GROWTH ENGINE

    17.2 GEOGRAPHIC OVERVIEW

    18 APAC         

    18.1 MARKET OVERVIEW

    18.2 MARKET SIZE & FORECAST

    18.3 APAC: PRODUCT SEGMENTATION

    18.4 APAC: MATERIAL SEGMENTATION

    18.5 APAC: BODY PART SEGMENTATION

    18.6 APAC: END USER SEGMENTATION

    18.7 KEY COUNTRIES

    18.7.1 CHINA: MARKET SIZE & FORECAST

    18.7.2 INDIA: MARKET SIZE & FORECAST

    18.7.3 JAPAN: MARKET SIZE & FORECAST

    18.7.4 SOUTH KOREA: MARKET SIZE & FORECAST

    18.7.5 AUSTRALIA: MARKET SIZE & FORECAST

    19 EUROPE

    19.1 MARKET OVERVIEW

    19.2 MARKET SIZE & FORECAST

    19.3 EUROPE: PRODUCT SEGMENTATION

    19.4 EUROPE: MATERIAL SEGMENTATION

    19.5 EUROPE: BODY PART SEGMENTATION

    19.6 EUROPE: END-USER SEGMENTATION

    19.7 KEY COUNTRIES

    19.7.1 GERMANY: MARKET SIZE & FORECAST

    19.7.2 FRANCE: MARKET SIZE & FORECAST

    19.7.3 THE UK: MARKET SIZE & FORECAST

    19.7.4 ITALY: MARKET SIZE & FORECAST

    19.7.5 SPAIN: MARKET SIZE & FORECAST

    20 NORTH AMERICA

    20.1 MARKET OVERVIEW

    20.2 MARKET SIZE & FORECAST

    20.3 NORTH AMERICA: PRODUCT SEGMENTATION

    20.4 NORTH AMERICA: MATERIAL SEGMENTATION

    20.5 NORTH AMERICA: BODY PART SEGMENTATION

    20.6 NORTH AMERICA: END-USER SEGMENTATION

    20.7 KEY COUNTRIES

    20.7.1 US: MARKET SIZE & FORECAST

    20.7.2 CANADA: MARKET SIZE & FORECAST

    21 LATIN AMERICA

    21.1 MARKET OVERVIEW

    21.2 MARKET SIZE & FORECAST

    21.3 LATIN AMERICA: PRODUCT SEGMENTATION

    21.4 LATIN AMERICA: MATERIAL SEGMENTATION

    21.5 LATIN AMERICA: BODY PART SEGMENTATION

    21.6 LATIN AMERICA: END-USER SEGMENTATION

    21.7 KEY COUNTRIES

    21.7.1 BRAZIL: MARKET SIZE & FORECAST

    21.7.2 MEXICO: MARKET SIZE & FORECAST

    21.7.3 ARGENTINA: MARKET SIZE & FORECASTS

    22 MIDDLE EAST & AFRICA

    22.1 MARKET OVERVIEW

    22.2 MARKET SIZE & FORECAST

    22.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

    22.4 MIDDLE EAST & AFRICA: MATERIAL SEGMENTATION

    22.5 MIDDLE EAST & AFRICA: BODY PART SEGMENTATION

    22.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

    22.7 KEY COUNTRIES

    22.7.1 TURKEY: MARKET SIZE & FORECAST

    22.7.2 SOUTH AFRICA: MARKET SIZE & FORECAST

    22.7.3 SAUDI ARABIA: MARKET SIZE & FORECAST

    22.7.4 EGYPT: MARKET SIZE & FORECAST

    22.7.5 NIGERIA: MARKET SIZE & FORECAST

    23 COMPETITIVE LANDSCAPE

    23.1 COMPETITION OVERVIEW

    23.2 MARKET SHARE ANALYSIS

    24 KEY COMPANY PROFILES

    24.1 ESSITY MEDICAL SOLUTIONS

    24.1.1 BUSINESS OVERVIEW

    24.1.2 ESSITY MEDICAL SOLUTIONS IN ORTHOPEDIC SPLINTS & CASTS MARKET

    24.1.3 PRODUCT OFFERINGS

    24.1.4 KEY STRATEGIES

    24.1.5 KEY STRENGTHS

    24.1.6 KEY OPPORTUNITIES

    24.2 3M

    24.3 ENVOIS

    24.4 BREG

    24.5 DEROYAL INDUSTRIES

    24.6 BAUERFEIND

    25 OTHER PROMINENT VENDORS

    25.1 ALCARE

    25.1.1 BUSINESS OVERVIEW

    25.1.2 PRODUCT OFFERINGS

    25.2 FRANK STUBBS COMPANY

    25.3 WEBER ORTHOPEDIC LP. DBA HELY & WEBER

    25.4 MEDI

    25.5 CAROLINA NARROW FABRIC

    25.6 THUASNE GROUP

    25.7 TRULIFE

    25.8 TYNOR

    25.9 ORTHOSYS

    25.10 DUK-IN

    25.11 PERFORMANCE HEALTH

    25.12 ALIMED

    25.13 LOHMANN & RAUSCHER

    25.14 ELITE ORTHOPAEDICS

    25.15 ALLARD USA

    25.16 BRACEABILITY

    25.17 VISSCO REHABILITATION AIDS

    25.18 BIRD & CRONIN

    25.19 DATT MEDIPRODUCTS

    25.20 PRIME MEDICAL

    26 REPORT SUMMARY

    26.1 KEY TAKEAWAYS

    26.2 STRATEGIC RECOMMENDATIONS

    27 QUANTITATIVE SUMMARY

    27.1 MARKET BY PRODUCT

    27.1.1 APAC: PRODUCT SEGMENTATION

    27.1.2 EUROPE: PRODUCT SEGMENTATION

    27.1.3 NORTH AMERICA: PRODUCT SEGMENTATION

    27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION

    27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

    27.2 MARKET BY MATERIAL

    27.2.1 APAC: MATERIAL SEGMENTATION

    27.2.2 EUROPE: MATERIAL SEGMENTATION

    27.2.3 NORTH AMERICA: MATERIAL SEGMENTATION

    27.2.4 LATIN AMERICA: MATERIAL SEGMENTATION

    27.2.5 MIDDLE EAST & AFRICA: MATERIAL SEGMENTATION

    27.3 MARKET BY BODY PART

    27.3.1 APAC: BODY PART SEGMENTATION

    27.3.2 EUROPE: BODY PART SEGMENTATION

    27.3.3 NORTH AMERICA: BODY PART SEGMENTATION

    27.3.4 LATIN AMERICA: BODY PART SEGMENTATION

    27.3.5 MIDDLE EAST & AFRICA: BODY PART SEGMENTATION

    27.4 MARKET BY END-USERS

    27.4.1 APAC: END USER SEGMENTATION

    27.4.2 EUROPE: END USER SEGMENTATION

    27.4.3 NORTH AMERICA: END USER SEGMENTATION

    27.4.4 LATIN AMERICA: END USER SEGMENTATION

    27.4.5 MIDDLE EAST & AFRICA: END USER SEGMENTATION

    27.5 GEOGRAPHY SEGMENTATION

    27.5.1 CASTS: GEOGRAPHY SEGMENTATION

    27.5.2 SPLINTS: GEOGRAPHY SEGMENTATION

    27.5.3 SYNTHETIC SPLINTS & CASTS: GEOGRAPHY SEGMENTATION

    27.5.4 PLASTER OF PARIS SPLINTS & CASTS: GEOGRAPHY SEGMENTATION

    27.5.5 UPPER BODY: GEOGRAPHY SEGMENTATION

    27.5.6 LOWER BODY: GEOGRAPHY SEGMENTATION

    27.5.7 ORTHOTIC & ORTHOPEDIC CLINICS: GEOGRAPHY SEGMENTATION

    27.5.8 HOSPITALS: GEOGRAPHY SEGMENTATION

    27.5.9 OTHERS: GEOGRAPHY SEGMENTATION

    28 APPENDIX

    28.1 ABBREVIATIONS

    ABOUT US:

    Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

    We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

    Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

    Click Here to Contact Us

    Call: +1-312-235-2040  
    +1 302 469 0707  
    Mail: [email protected]

    Photo: https://mma.prnewswire.com/media/1985732/ORTHOPEDIC_SPLINTS_AND_CASTS_MARKET.jpg
    Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

    Arizton Logo (PRNewsfoto/Arizton Advisory & Intelligence)

    Arizton Logo (PRNewsfoto/Arizton Advisory & Intelligence)

    Cision

    Cision

    View original content to download multimedia:https://www.prnewswire.com/news-releases/3d-printing-revolutionizing-the-orthopedic-splints-and-casts-market-with-tremendous-opportunities-the-market-to-mark-usd-3-34-billion-by-2027–arizton-301724677.html

    SOURCE Arizton Advisory & Intelligence

  • Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

    Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

    Chronic kidney disease (CKD) is one of the leading causes of death globally, which affects 13.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the world’s population [1]. With deterioration in renal function, this leads to the onset of CKD-related complications, such as uremia, anemia, and electrolyte disorders [2]. These complications often manifest as symptoms ranging from pruritus, pain, and insomnia to muscle cramps. This in turn has negative implications on patients’ quality of life [3,4]. Importantly as CKD patients approach end-stage renal disease (ESRD), the prevalence and severity of such symptoms increase [5].

    Despite medical breakthroughs and the advent of new therapies in the past decades, optimal treatments for some of the symptoms resulting from CKD-related complications remained unclear, possibly due to their complex pathophysiology. A case in point is uremic pruritus, which is found in around 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of pre-dialysis CKD patients and 40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of ESRD patients [6]. Although prevalent treatments include the use of emollients, gabapentin, and antihistamines, data related to their efficacy were often derived from small studies and their use is limited by adverse effects [7].

    The use of alternative medical systems (AMS) which forms a key pillar of complementary and alternative medicine (CAM) has increased in the past 20 years [8]. AMS is defined as “entire systems of health theory and practice that developed separately from conventional medicine” [9]. Notably, around 18{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of dialysis patients have utilized some form of AMS [10,11]. In addition, prescription of AMS therapies such as traditional Chinese medicine (TCM) by professional practitioners often aids in minimizing the risk of side effects, hence increasing their appeal as potential therapeutic alternatives [11].

    Prior studies have shown that AMS is effective in reducing symptoms such as pain, nausea, and fatigue in non-CKD patient populations. For instance the use of TCM formulas, such as Liu Junzi Tang and Xiao Banxia Plus Fuling have demonstrated efficacy in treating cancer-related pain and chemotherapy-related nausea and vomiting [12]. In addition, Chinese herbs such as Curcuma longa and Panax ginseng among patients with malignancies have shown efficacy in promoting apoptosis of cancer cells and inhibiting tumor metastasis [13]. Another study showed that a multi-modal Ayurvedic treatment approach was effective in reducing knee osteoarthritis symptoms, such as pain and stiffness, and improving function [14]. With increasing research supporting the use of AMS, this has led to a rise in healthcare institutions adopting and providing such integrated services which are supported by insurance coverage [15].

    Among CKD patients, multiple studies have also been conducted to assess the efficacy of AMS in the treatment of CKD-related conditions and symptoms such as uremic pruritis and anemia. For instance, a study that assessed the efficacy of homeopathy verum among CKD patients showed a reduction in pruritus symptoms by 49{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} after 30 days of treatment [16]. Another study that evaluated the use of TCM patients with glomerulonephritis showed improvement in hemoglobin after 24 weeks of therapy [16,17].

    Existing reviews which have assessed the role of AMS are currently limited to specific indications, such as uremic pruritus [18], use of subtypes of AMS in specific CKD subgroups, such as consumption of Chinese herbal medicine in diabetic kidney disease [19], and specific AMS therapies, such as use of Astragalus [20,21]. This review aimed to summarize and evaluate the broad roles and efficacy of AMS as potential alternative therapeutic options for CKD patients. Findings from the review will aid physicians in gaining a better understanding of the efficacy of AMS for CKD patients, which can aid in facilitating purposeful discussions with patients who are using or considering these therapies.

    Methods

    Protocol and Registration

    The protocol for this study was registered on Open Science Framework (https://osf.io/ymks8/) and was composed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and Synthesis without Meta-Analysis (SWiM) reporting guidelines [22,23].

    Information Sources and Search

    A literature search was conducted in MEDLINE, Embase, Scopus, CENTRAL, CINAHL, and PsycINFO. There was no start date restriction, and studies up to April 2022 were included. Key terms related to CKD, randomized controlled trials (RCT), and AMS were included in the searches. The search terms were adapted from other systematic reviews and the full search strategy is available in Appendix 1 [18,24-26].

    Eligibility Criteria

    With regards to inclusion criteria, full-text articles in English language which involved RCTs evaluating the use of AMS in adult CKD patients (>18 years old) were included. As defined by the National Center for Complementary and Integrative Health (NCCIH), AMS is a broad category encompassing a variety of medical modalities and refers to an entire system of theory and practice which developed separately from conventional medicine [15]. In this review, we included TCM, naturopathy, homeopathy, and ayurvedic medicine. Non-RCTs, case series, other systematic reviews, and meta-analyses were excluded.

    Description of Main Types of AMS

    TCM: TCM is a system of medical practice which originated in China and adopts a holistic approach to the medical treatment of a patient based on “syndrome differentiation.” It focuses on the integrity of the human body by emphasizing the intimate relationship between the body and its social and natural environment, as well as dynamic balance of movement [27]. The basic tenet of TCM is based on the flow and balance of vital energy, Qi, which flows through channels in the body called meridians that connect various organs and tissues [28]. Diseases are believed to be brought about by the imbalance of Qi. Hence, by restoring balance via acupoints or intake of herbs, TCM seeks to promote individual wellness and prevent diseases [29].

    Naturopathy: Naturopathy is a form of medical practice which is rooted in vitalism and folk medicine and, promotes natural and self-healing ideologies [30]. The unique attribute of naturopathic medicine lies in the reprioritization of the order of therapeutics with increased emphasis on preventive behaviors, lifestyle modifications, nutrition, and exercise, over medical or surgical interventions [31].

    Homeopathy: Homeopathy entails the therapeutic administration of substances derived from plants, minerals, or animals that produce effects that correspond to the clinical manifestation of diseases [32]. Its practice is centered on two following theories: “like cures like” and “law of minimum dose.” “Like cures like” refers to the belief that diseases can be treated with substances that produce similar symptoms in healthy individuals, and “law of minimum dose” refers to the belief that the lower the dose the greater its therapeutic efficacy [32].

    Ayurvedic medicine: Ayurvedic medicine is one of the oldest alternative medical systems which involves the use of therapeutics derived predominantly from plants, animals, minerals, diet, exercise, and lifestyle changes. Its therapies are centered on the principle of “Panchakarma,” which comprises five karmas (actions) to rejuvenate and remove toxins from one’s body [33].

    Study Selection and Data Collection Process

    Citations retrieved from the six databases were extracted into Endnote X9 software (Philadelphia, PA: Clarivate) and duplicated citations were removed. During the initial article screening, two independent reviewers (WY and SW) reviewed the titles and abstracts of articles to select relevant articles. Thereafter, the full texts of the identified articles were evaluated. All discrepancies during the article screening process were resolved by discussion with a third reviewer (JJ). Hand-searching of references within identified articles was also performed to enhance the comprehensiveness of the search. A standardized Microsoft Excel data collection form was used for data extraction, and details related to the study characteristics, studied indications of intervention, efficacy, and safety were collected.

    Management of Missing Data

    For studies with missing data, authors were contacted for clarification to enhance the comprehensiveness of this review. Missing information that could not be retrieved after two email reminders were labeled as unavailable.

    Risk of Bias in Individual Studies

    The Cochrane Risk of Bias tool version 2.0 (Oxford, England: Cochrane) was utilized in the assessment of the included RCTs [34]. Two independent reviewers (Teo and Chu) performed the risk of bias assessment (Appendix 2). The instrument comprises of the following five domains: risk of bias arising from the randomization process, deviations from intended interventions, missing outcome data, outcome measurement, and selection of reported results. Using the responses derived from the five domains, the overall risk of bias for the individual studies was rated as “low,” “some concerns,” or “high” risk of bias.

    Assessment of Heterogeneity

    Clinical and methodological heterogeneity of included studies were analyzed to evaluate if meta-analyses could be performed for specific interventions in this study. Clinical heterogeneity describes variation in characteristics of study participants, intervention, or outcomes while methodological heterogeneity describes variation in study design and risk of bias. This was performed by two independent reviewers (Yeam and Seng). In view of the clinical and methodological heterogeneity across the included studies, a narrative review of the RCTs was conducted.

    Synthesis of Data

    With regard to the efficacy of AMS interventions, the response rates and any changes in patients’ quality of life were recorded. Additionally, the safety profile of each intervention was evaluated and the reported prevalence, severity, and outcomes of adverse effects were tabulated. The adverse events reported in included studies were categorized using the Common Terminology Criteria for Adverse Events (CTCAE) [35].

    Summary Measures

    Descriptive statistics were utilized to summarize the characteristics of all included studies. The principal summary measures evaluated in this study were the studied indications, efficacy of each AMS, and safety profile of each AMS.

    Results

    Study Selection

    Out of 14,583 retrieved citations, 33 full-text articles were included in this review. The inclusion and exclusion criteria for the studies are shown in Figure 1. The percentage of agreement of articles between the reviewers was 94.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and all disagreements were resolved after discussion.

    Study Characteristics

    Types of AMS studied: Table 1 shows the characteristics of included studies. Among the four main types of AMS, TCM was the most studied (n=20, 60.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [3,7,17,36-52], followed by Ayurveda (n=6, 18.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53-58], naturopathy (n=5, 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [59-63], and homeopathy (n=2, 6.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [16,64].

    Study (year of publication) Study design Number of patients in treatment and control arm Indication for use of intervention Treatment Comparator Country Patient population Mean age of patients (SD) Gender (male) ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Traditional Chinese medicine (n=20)
    Li et al. (2015) [41] Double-blinded parallel arm T1:66, C1:32, T2:56, C2:26 Renal function 8 g TSF granules and ARB BID x 24 weeks 8 g placebo TID and ARB BID x 24 weeks China Non-dialysis CKD patients T1:59.5 (10.1), C1:56.7 (9.3), T2:58.9 (9.0), C2:60.8 (10.0) T1:54.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C1:53.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:58.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C2:53.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ma et al. (2013) [43] Parallel arm T:25, C:20 Renal function 150 mL ZSTL solution BID x 3 months 10 mg benazepril QD x 3 months China Early DN patients T:57, C:57 T:40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2012) [17] Double-blinded parallel arm T1:192, T2:191, C:189 Renal function T1: TCM granules BID x 24 weeks, T2: TCM granules BID and 10mg benazepril QD x 24 weeks 10 mg benazepril QD and TCM placebo TID x 24 weeks China CKD stage 3 T1:47.3 (10.9), T2:49.3 (11.4), C:49.0 (10.5) T1:54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:47.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:47.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Yu et al. (2017) [50] Single-blinded parallel arm T:28, C:25 Renal function Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Sham acupuncture QD x 3 months China CKD stage 2-4 T:58.5, C:61.0 T:89.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:88.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Zhao et al. (2020) [52] Double-blinded parallel arm T:171, C:172 Renal function Herbal granules TID x 6 months Placebo granules x TID 6 months China CKD stage 3 T:51.89 (13.12), C:52.03 (12.62) T:62.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:70.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xiang et al. (2016) [47] Parallel arm T:51, C:51 Renal function QDDHGa tablets BID x 12 weeks ARB tablets (minimum dosage) China DN patients T:57.21 (13.20), C:58.16 (11.59) T:24{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xu et al. (2016) [49] Double-blinded parallel arm T:91, C:86 Renal function 500 mg GS-Rb1 (ginseng extract) QD x 6 months  Placebo tablets QD x 6 months China CKD stage 2-3 T:59.2 (8.5), C:58.4 (7.5) T:72.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:70.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Chen et al. (2013) [37] Parallel arm T:95, C:95 Proteinuria 9.6 g of Shenqi particle TID x 48 weeks Routine care China Non-dialysis CKD patients T:49 (14), C:53 (12) T:36.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:68.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ge et al. (2013) [39] Parallel arm T:34, C:31 Proteinuria  40 mg TWHF TID x 3 months followed by 20 mg TWHF TID x 3 months 80 mg valsartan BID x 6 months China DN patients T:51.9 (9.8), C:51.0 (8.9) T:58.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:54.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Li et al. (2020) [42] Double-blinded parallel arm T:735, C:735 Proteinuria Huangkui capsule TID x 12 months Losartan potassium tablet QD and placebo capsules TIW x 12 months China CKD stage 1-3a T:37.7 (10.9), C:37.1 (10.4) T:48.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:46.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Zhang et al. (2014) [51] Parallel arm T1:133, T2:136, C:135 Proteinuria T1: Huangkui capsule TID x 6 months, T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months  Losartan tablet potassium QD x 6 months  China Non-dialysis CKD patients T1:37.3 (12.5), T2:37.1 (11.1), C:38.1 (12.7) T1:50.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:47.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:53.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Xiong et al. (2020) [48] Parallel arm T:62, C:62 Proteinuria 60 mg TWHF and 160 mg valsartan QD x 24 weeks 160 valsartan QD x 24 weeks China Non-dialysis CKD patients T:50.3 (11.8), C:49.6 (12.3) T:69.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:72.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Che-Yi et al. (2005) [36] Double-blinded parallel arm T:20, C:20 Uremic pruritus Acupuncture at Quchi (L11) acupoint TIW x 1 month Sham acupuncture TIW x 1 month China ESRD T:62.4 (9.1), C:63.2 (7.5) T:45.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:50.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Gao et al. (2002) [38] Double-blinded parallel arm T:34, C:34 Uremic pruritus Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month Sham acupuncture BIW x 1 month China ESRD 43.6 59.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Nahidi et al. (2018) [7] Single-blinded parallel arm T:15, C:11 Uremic pruritus Acupuncture at various acupoints TIW x 6 weeks Sham acupuncture TIW x 6 weeks Iran HD T:54.7 (11.4), C:41.4 (16.2) T:60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:73{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ono et al. (2015) [3] Parallel arm T:23, C:17 Fatigue, insomnia, itchiness, and pain Acupuncture QIW x 2 months Routine care Japan HD T:70.0 (9.6), C:67.3 (13.0) NI
    Su et al. (2009) [44] Parallel arm T:31, C:30 QoL Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months Heat pad therapy to acupoints TIW x 3 months China ESRD T:61.07 (13.9), C:58.6 (12.6) T:51.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:56.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2019) [45] Single-blinded parallel arm T:40, C:40 Wnt/β-catenin signaling pathway Qingshen granules TID x 3 months Placebo granules TID x 3 months China CKD stage 3-5 T:52.1 (10.4), C:54.9 (9.2) T:55{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:48{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Wang et al. (2020) [46] Parallel arm T:136, C:146 Immune function Qingshen granules TID x 3 months Routine care China CKD stage 3-5 T:54.0 (10.5), C:51.8 (12.0) T:55.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:57.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Li et al. (2009) [40] Parallel arm T:32, C:32 Vascular endothelial function TBN tablets (gingko extract) TI x 8 weeks Routine care China Early DN patients T:66.5 (71.1), C:67.2 (7.2) T:53.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ayurveda (n=6)
    Alam et al. (2020) [53] Parallel arm T:70, C:66 Renal function Sativa oil QD and alpha-keto amino acid tablets TID x 3 months Alpha-keto amino acid tablets TID x 3 months India CKD stage 3-4 T:49.2, C:48.8 T:58.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:51.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Fallahzadeh et al. (2012) [54] Double-blinded parallel arm T:30, C:30 Renal function 140 mg silymarin tablet QD x 3 months Placebo tablet QD x 3 months Iran Non-dialysis CKD patients T:55.9 (8.3), C:57.6 (7.5) T:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Hoseini et al. (2019) [55] Parallel arm T:22, C:22 Renal function Camel milk BID x 3 months Routine care Iran CKD stage 3-4 56.7 (11.8) 52.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Khajehdehi et al. (2011) [56] Double-blinded parallel arm T:28, C:28 Renal function 140 mg silymarin TID x 3 months Placebo tablet TID x 3 months Iran Non-dialysis CKD patients T:55.9 (8.3), C:57.6 (7.5) T:50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Makhlough et al. (2010) [57] Double-blinded parallel arm T:17, C:17 Uremic pruritus 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Placebo ointment QID x 4 weeks Iran ESRD 57 (18.6) 41.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Pingali et al. (2020) [58] Double-blinded parallel arm T1:18, T2:18, C:19 Hyperuricemia T1:500 mg of beleric capsule taken QD T2: 1000 mg of beleric capsule taken QD C:40 mg of febuxostat taken QD India CKD stage 2-3 T1:53.2 (8.9), T2:50.8 (8.8), C:51.0 (9.8) T1:72.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, T2:77.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:73.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Naturopathy (n=5)
    Khan et al. (2014) [60] Double-blinded parallel arm T:80, C:80 Malnutrition  Alpha-keto amino acid tablets TID x 3 months Placebo tablets TID x 3 months India Non-dialysis CKD patients T:45.0, C:45.0 T:59.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:57.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Prakash et al. (2004) [61] Double-blinded parallel arm T:21, C:19 Malnutrition  Keto amino acid tablets QD x 9 months Placebo tablets QD x 9 months India CKD stage 3-4 T:52.8 (14.1), C:55.9 (17.6) T:55.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Sedaghattalab et al. (2021) [62] Double-blinded parallel arm T:22, C:23 Inflammation Watercress extract QD x 1 month Placebo extract QD x 1 month Iran HD T:58.9 (16), C:63.1 (13) NI
    Zare et al. (2019) [63] Double-blinded parallel arm T:19, C:21 Inflammation Garlic extract tablets TIW x 2 months Placebo tablets TIW x 2 months Iran PD T:56.0 (16.1), C:52.8 (18.8) T:42.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:42.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Boldaji et al. (2019) [59] Crossover trial T:22, C:19 Hypertension, stress, and inflammation Pomegranate juice TIW x 2 months Routine care Iran ESRD 47.8 (13.3) 61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Homeopathy (n=2)
    Cavalcanti et al. (2003) [16] Double-blinded parallel arm T:11, C:9 Uremic pruritus Homeopathic verum medicationb administered Placebo medication administered Brazil HD T:47, C:57 T:64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:56{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Silveira et al. (2019) [64] Double-blinded parallel arm T:18, C:14 Renal function Brazilian green propolis pills BID x 3 months Placebo pills BID x 3 months Brazil CKD stage 1-5 T:52.8 (14.1), C:55.9 (17.6) T:55.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, C:43.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Overview of study design and patient characteristics in included studies are as follows: the majority of the studies were conducted in Asia (n=31, 93.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), whereas most of the studies were performed in China (n=18, 54.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Out of all reviewed studies, 20 (60.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) were blinded to randomized controlled trials. The sample size was greater than 50 patients in 21 (63.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) trials (Table 1). Non-dialysis patients were recruited in seven studies (21.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), whereas ESRD patients were recruited in five studies (15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The average duration of follow-up for all studies was 4.9 months (Table 2).

    Study (year of publication) Indication for use of intervention Treatment (dose and duration if available) Comparator (dose and duration if available) Tool(s) used to assess outcomes Outcome Improvement symptoms (yes / no) Percentage reductiona/improvement in symptoms (if available) Follow-up duration
    Traditional Chinese medicine (n=20)
    Li et al. (2015) [41] Renal function 8 g TSF granules TID and ARB BID x 24 weeks 8 g placebo TID and ARB BID x 24 weeks WHOQOL-BREF, DQOL UAER (μg/min) (pre vs post): 105.39±77.29 vs 88.37±108.46, p=0.021 Yes -16.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER) 6 months
    24 h urinary protein (g/24 h) (pre vs post): 1.12±0.75 vs 0.91±0.90, p=0.017 -18.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (24 h urinary protein)
    Ma et al. (2013) [43] Renal function 150 mL ZSTL solution BID x 3 months 10 mg benazepril QD x 3 months Radioimmunoassay, ELISA HbA1c ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (baseline vs mean change from baseline): 10.68 (8.48, 13.96) vs -4.29 (-5.85, -2.79), p<0.05. Yes -40.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (HbA1c) 9 months
    UAER (μg/min) (baseline vs mean change from baseline): 211.52 (164.58, 243.89) vs -106.99 (-121.29, -85.55), p<0.05 -50.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER)
    SCr (μmol/L) (baseline vs mean change from baseline): 87.17 (70.59, 110.25) vs -3.33 (-11.02, 2.15), p<0.05 -3.82{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    CCR (mL/min) (baseline vs mean change from baseline): 139.86 (129.58, 149.52) vs -9.22 (-13.42, -5.82), p <0.05 -6.59{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CCR)
    Wang et al. (2012) [17] Renal function T1: TCM granuleb BID x 24 weeks. T2: TCM granuleb BID and 10 mg benazepril QD x 24 weeks. 10 mg benazepril QD and TCM placebo TID x 24 weeks MDRD study equation, TCM assessing sheets eGFR (mL/min/1.73 m2) (pre vs post): T1: 45.26±10.12 vs 48.46±15.90, p<0.05. T2: 44.68±9.82 vs 48.31±17.50, p<0.05. Yes 7.07{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; T1), 8.12{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; T2) 6 months
    24 h proteinuria (mg/24 h) (pre vs post): T1: 725.98 vs 990.00, p<0.05. T2: 590.00 vs 453.50, p<0.05 36.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria; T1), -21.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria; T2)
    Urinary albumin/creatinine (mg/gCr) (pre vs post): T2: 0.30 vs 0.22, p<0.05 -26.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary albumin/creatinine; T2)
    Hb (g/L) (pre vs post): T1: 127.31±18.47 vs 129.57±21.82, p<0.05 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb; T1)
    Yu et al. (2017) [50] Renal function Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Sham acupuncture QD x 3 months NI SCr levels (mg/dL) (T vs C): baseline: 1.45 vs 1.67, p=0.1298. Post-intervention: 1.41 vs 1.65, p=0.0489. 3-month follow-up: 1.32 vs 1.81, p=0.0467 Yes -2.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs post), -9.00{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre- vs 3 months follow-up) 6 months
    eGFR (mL/min/1.73m2) (T vs C): Baseline: 51.85 vs 42.50, p=0.0855. Post-intervention: 54.50 vs 43.60, p=0.0470. 3-month follow-up: 59.90 vs 40.80, p=0.0191 5.11{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; pre vs post), 15.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; pre-intervention vs 3 months follow-up)
    hs-CRP (mg/dL) (T vs C): Baseline: 1.10 vs 0.79, p=0.4361. Post-intervention: 0.80 vs 0.90, p=0.8773 -27.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (hs-CRP pre vs post)
    Zhao et al. (2020) [52] Renal function Herbal granulec TID x 6 months Placebo granules x TID 6 months Dye-binding method, Cerebrospinal fluid protein test kit, Determiner L CRE kit SCr (μmol/L) (pre vs weeks 16, 20 and 24): 148.42±35.90 vs 130.19±29.79, 130.08±30.57, 130.78±32.55, p<0.05 Yes -12.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 16 weeks), -12.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 20 weeks), -11.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr; pre vs 24 weeks) 6 months
    Xiang et al. (2016) [47] Renal function QDDHG tablets BID and ARB (minimum dosage) x 12 weeks ARB tablets (minimum dosage) Guidelines for clinical research of Chinese medicine Albumin (mg/24h) (within treatment group, baseline vs 4 vs 8 vs 12 week): 85.30 (66.00, 176.30) vs 61.50 (49.00, 110.20), p<0.05 vs 51.00 (37.00, 90.00), p<0.05 vs 41.40 (29.00, 68.00), p<0.05 Yes -27.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 4 weeks), -40.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 8 weeks), -43.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Albumin; 12 weeks) 3 months
    Proteinuria (g/24h) (within treatment group, baseline vs 4 vs 8 vs 12 week): 0.20 (0.10, 0.30) vs 0.10 (0.10, 0.20), p<0.05 vs 0.10 (0.10, 0.20), p<0.05 vs 0.10 (0.10, 0.20), p<0.05 -50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Proteinuria; 4, 8, 12 weeks)
    Albumin/creatinine (mg/mol) (within treatment group, baseline vs 4 vs 8 vs 12 week): 20.70 (11.00, 30.50) vs 16.30 (8.10, 25.00), p<0.05 vs 15.00 (7.20, 20.60), p<0.05 vs 10.10 (5.60, 17.00), p<0.05 -21.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 4 weeks), -27.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 8 weeks), -51.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (albumin/creatinine; 12 weeks)
    Xu et al. (2016) [49] Renal function 500 mg GS-Rb1 (ginseng extract) QD x 6 months  Placebo tablets QD x 6 months ELISA Creatinine and urea level (T vs C): 6 months, p<0.01. 12 months, p<0.01 Yes 12 months
    Oxidative stress markers (T vs C): 6 months, p<0.01. 12 months, p<0.05
    TNF-a level (T vs C): 6 months, p<0.05
    Chen et al. (2013) [37] Proteinuria 9.6 g of Shenqi particle TID x 48 weeks Routine care MDRD study equation Proteinuria (g/d) (pre vs post): 5.34±2.74 vs 2.04±2.15, p<0.001 Yes -61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months
    eGFR (mL/min/1.73 m2) (pre vs post): 84.6±27.0 vs 100.7±37.5, p=0.001 19.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    Ge et al. (2013) [39] Proteinuria 40 mg TwHF TID x 3 months, 20 mg TwHF TID x 3 months. 160 mg valsartan capsules QD x 6 months Trichloroacetic acid method, Jaffe reaction, MDRD study equation, high-performance liquid chromatography Urinary protein (g/24 h) (pre vs 1 month, pre vs 3 months, pre vs 6 months): 4.99±2.25 vs 3.23±2.57, p<0.01. 4.99±2.25 vs 2.83±1.57, p<0.01. 4.99±2.25 vs 2.99±1.81, p<0.01 Yes -35.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 1 months), -43.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 3 months), -40.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (urinary protein; 6 months) 6 months
    eGFR (mL/min/1.73 m2) (pre vs 6 months): 43.07±21.65 vs 38.71±23.66, p<0.05 -10.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR; 6 months)
    Li et al. (2020) [42] Proteinuria Huangkui capsule TID x 12 months Losartan potassium tablet QD and placebo capsules TIW x 12 months NI Proteinuria (mg/24 h) (pre vs post): 1238.9±667.4 vs 1008.8±1104.7, p<0.001 Yes -18.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months
    Zhang et al. (2014) [51] Proteinuria T1: Huangkui capsule TID x 6 months. T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months. Losartan tablet potassium QD x 6 months Biuret method, sarcosine oxidase assay Proteinuria within T1 (pre vs 12 vs 24 weeks): 1045±420 vs 762±533, p<0.001 vs 537±409, p<0.001 Yes T1: -27.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 12 weeks), -48.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 24 weeks) 6 months
    Proteinuria within T2 (pre vs 12 vs 24 weeks): 1073±439 vs 783±658, p<0.001 vs 529±509, p<0.001. T2: -27.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 12 weeks), -50.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pre vs 24 weeks).
    Xiong et al. (2020) [48] Proteinuria 60 mg TWHF and 160 mg valsartan QD x 24 weeks 160 valsartan QD x 24 weeks CKD-EPI equation Proteinuria (g/24 h) (T vs C, PP analysis): 3.16±0.62 vs 4.28±0.85, p<0.001 Yes PP: -26.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria)  6 months
    Serum albumin (g/L) (T vs C, PP analysis): 37.65±4.31 vs 33.59±4.56, p<0.001 PP: 12.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (serum albumin)
    Proteinuria (g/24 h) (T vs C, ITT analysis): 3.36±0.83 vs 4.52±1.06; p<0.001 ITT: -25.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria)
    Serum albumin (g/L) (T vs C, ITT analysis): 36.91±4.42 vs 34.67±4.75, p=0.008 ITT: 6.46{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (serum albumin)
    Che-yi et al. (2005) [36] Uremic pruritus Acupuncture at Quchi (L11) acupoint TIW x 1 month Sham acupuncture TIW x 1 month Validated questionnaire Pruritus scores (pre vs post vs 3 months follow-up): 38.2±4.8 vs 17.3±5.5 vs 16.5±4.9, p<0.001 Yes -54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores; pre- vs post-intervention), -56.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores; pre-intervention vs 3 months follow-up) 3 months
    Gao et al. (2002) [38] Uremic pruritus Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month Sham acupuncture BIW x 1 month NI Number of patients (complete alleviation vs improvement vs no effect): 24 (70.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) vs 9 (26.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) vs 1 (2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Yes 3 months
    Nahidi et al. (2018) [7] Uremic pruritus 30 minutes of acupuncture, for six weeks, at the following acupoints: Sp6, Sp10, Lv3, Li4, Li11. 30 minutes of sham acupuncture, for 6 weeks. VAS Pruritus scores (pre vs post): 9.87±0.35 vs 3.93±2.85, p<0.001 Yes -60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus scores) 6 weeks
    Ono et al. (2015) [3] Fatigue, insomnia, itchiness, and pain Acupuncture QIW x 2 months Routine care VAS, EQ-5D Headache score (pre vs post): 17.1±26.1 vs 6.2±13.5, p<0.05. Yes -63.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (headache score)  3 months
    Blurred vision score (pre vs post): 33.4±32.7 vs 17.0±22.2, p<0.05. -49.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (blurred vision score) 
    Dizziness score (pre vs post): 13.0±21.4 vs 1.4±6.3, p<0.05. -89.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (dizziness score) 
    Ear buzzing (pre vs post): 17.9±27.2 vs 8.0±14.7, p<0.05 -55.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (ear buzzing)
    Cervical pain (pre vs post): 37.7±39.1 vs 25.3±29.7, p<0.05 -32.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (cervical pain) 
    Stiff shoulders (pre vs post): 29.9±28.6 vs 12.5±21.6, p<0.05 -58.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (stiff shoulders) 
    Back pain (pre vs post): 38.5±33.7 vs 9.3±18.1, p<0.05 -58.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (back pain)
    Lower limb pain (pre vs post): 29.4±36.4 vs 17.1±23.3, p<0.05 -41.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (lower limb pain) 
    Numbness in upper limb (pre vs post): 18.9±30.4 vs 4.0±29.5, p<0.05 -78.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (numbness in upper limb) 
    Numbness in lower limb (pre vs post): 21.9±34.9 vs 11.0±26.2, p<0.05 -49.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (numbness in lower limb) 
    Itchiness (pre vs post): 38.7±40.7 vs 29.3±31.5, p<0.05 -24.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (itchiness)
    Difficulty in sleeping (pre vs post): 34.8±36.9 vs 12.8±22.5, p<0.05 -63.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (difficulty in sleeping)
    Utility in treatment group (pre vs post): 0.66±0.15 vs 0.76±0.17, p<0.05 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (utility)
    Su et al. (2009) [44] QoL Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months Heat pad therapy to acupoints TIW x 3 months Heart rate variability analyser, WHOQOL-BREF questionnaire LF activity (pre vs post): 49.99±79.08 vs 131.71±214.36, p=0.01 Yes 163{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (LF activity) 3 months
    Fatigue index (pre vs post): 133.90±20.43 vs 121.71±32.68, p=0.02 -9.10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (fatigue index)
    Psychological domain (pre vs post): 18.16±4.30 vs 19.39±0.72, p=0.02 6.77{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (psychological domain)
    Environmental domain (pre vs post): 29.87±4.04 vs 32.00±4.85, p=0.00. 7.13{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (environmental)
    Wang et al. (2019) [45] Wnt/β-catenin signaling pathway Qingshen granules TID x 3 months Placebo granules TID x 3 months ELISA Effective rates of TCM symptom (T vs C): 80{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} vs 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, p=0.024 Yes 3 months
    eGFR (mL/min) (T vs C): 15.9±3.2 vs 14.0±4.0, p=0.019 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    HIF-1𝛼 (ng/mL) (T vs C): 0.66±0.16 vs 1.39±0.17, p≤0.001 -61.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (HIF-1𝛼)
    Wnt1 (pg/mL) (T vs C): 314.2±85.8 vs 382.8±85.3, p=0.001 -16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Wnt1)
    𝛽-catenin (pg/mL) (T vs C): 416.5±13.6 vs 462.1±15.1, p ≤0.001 -10.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (𝛽-catenin)
    𝛼-SMA (KU/L) (T vs C): 20.5±3.1 vs 23.5±4.1, p≤0.001 -20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (𝛼-SMA)
    E-cadherin (ng/mL) (T vs C): 2166.9±398.6 vs 2370.7±468.0, p=0.039 -15.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (E-cadherin)
    Wang et al. (2020) [46] Immune function Qingshen granules TID x 3 months Routine care Flow cytometry, ELISA CD4+/CD8+ T cell (pre vs post): 1.98±0.86 vs 1.58±0.72, p<0.05. Yes -20.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CD4+/CD8+ T cell) 3 months
    Th17 cell (pre vs post): 2.51±1.05 vs 1.70±0.83, p<0.01. -32.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Th17)
    NF-κB p65 (pre vs post): 36.84±12.96 vs 24.86±1.97, p<0.05 -32.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (NF-κB p65)
    IL-17 (pre vs post): 28.62±13.53 vs 19.78±12.25, p<0.05 -30.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-17)
    IL-6 (pre vs post): 77.13±20.54 vs 58.42±18.25, p<0.05 -24.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6)
    TNF-α (pre vs post): 110.34±23.76 vs 75.49±22.80, p<0.01 -31.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TNF-α)
    TRAF6 (pre vs post): 4.94±1.82 vs 2.85±1.53, p<0.01 -42.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TRAF6)
    FN (pre vs post): 93.42±20.36 vs 62.86±19.35, p<0.01 -32.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (FN)
    Col-IV (pre vs post): 36.85±14.58 vs 24.36±13.36, p<0.01 -33.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Col-IV)
    Total effective rate (T vs C): 79.41{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} vs 67.12{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, p<0.05.
    Li et al. (2009) [40] Vascular endothelial function TBN tablets (gingko extract) TID x 8 weeks Routine care Chemical colorimeter, Radioimmunoassay, ELISA, Siemens Sequoia 512 color Doppler ultrasonography UAER (μg/min) (pre vs post): 153.30±63.28 vs 85.15±36.82, p<0.01 Yes -44.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (UAER) 3 months
    SCr (μmol/L) (pre vs post): 120.76±17.83 vs 105.67±18.13, p<0.01 -12.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    NO (μmol/L) (pre vs post): 50.16±24.64 vs 70.65±28.71, p<0.01 40.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (NO)
    vWF ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post): 182.05±64.13 vs 128.56±48.98, p<0.01 -29.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (vWF)
    BAID responsive change ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post): 4.91±2.31 vs 6.78±3.89, p<0.01 38.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BAID responsive change)
    Ayurveda (n=6)
    Alam et al. (2020) [53] Renal function Sativa oil QD and alpha-keto amino acid tablets TID x 3 months Alpha-keto amino acid tablets TID x 3 months Hemogram, renal function test, serum electrolyte test Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (g/dL) (pre vs post): 8.84±1.31 vs 10.24±1.10, p<0.001 Yes 15.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) 3 months
    24-h TUV (mL/day) (pre vs post): 1250.69±303.74 vs 1660.14±258.78, p<0.001 32.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUV)
    eGFR (mL/min) (pre vs post): 22.71±7.28 vs 42.42±17.38, p<0.001 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR)
    Fallahzadeh et al. (2012) [54] Renal function 140 mg silymarin tablet QD x 3 months Placebo tablet QD x 3 months Jaffé method, ELISA MDA assay, MDRD study equation, nephelometry, high-performance liquid chromatography, mercury sphygmomanometer Urinary TNF-α (pg/mg) (change from baseline): -3.45 (-5.44 to -1.46), p<0.05 Yes 2 months
    Urinary MDA (nmol/mg) (change from baseline): -1.5 (-2.87 to -0.13, p<0.05
    Serum MDA (μmol/L) (change from baseline): -3.43 (-6.02 to -0.83), p<0.05
    Hoseini et al. (2019) [55] Renal function Camel milk BID x 3 months Routine care MDRD eGFR (pre vs post): 26.9±7.39 vs 31.45±8.99, p=0.001 Yes 16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (eGFR) 3 months
    SCr levels (pre vs post): 2.58±0.71 vs 2.2±0.48, p=0.01 -14.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    BUN (pre vs post): 60.31±22.61 vs 44.38±14.29, p=0.0001 -26.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BUN)
    Khajehdehi et al. (2011) [56] Renal function 140 mg silymarin TID x 3 months Placebo tablet TID x 3 months ELISA Proteinuria (mg/24h) (pre vs post, patients with type 2 diabetic nephropathy): 4328.7±3038.2 vs 2354.7±1800.1, p=0.001 Yes -45.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 2 months
    IL-8 (pg/mL) (pre vs post, patients with type 2 diabetic nephropathy): 99.1±97.9 vs 43.6±55.0, p=0.002 -56.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-8)
    TGF-β (pg/mL) (pre vs post, patients with overt type 2 diabetic nephropathy): 522.3±189.2 vs 397.3±55.2, p=0.006 -23.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TGB-β)
    IL-8 (pg/mL) (pre vs post, patients with overt type 2 diabetic nephropathy): 41.4±50.3 vs 30.6±75.2, p=0.02 -26.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-8)
    Makhlough et al. (2010) [57] Uremic pruritus 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Placebo ointment QID x 4 weeks Uremic pruritus scoring questionnaire by Duo Pruritus score (T vs C): 2.5±2.5 vs 7.2±5.5, p<0.05 Yes -84.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score)  
    Pingali et al. (2020) [58] Hyperuricemia T1:500 mg of beleric capsule taken QD. T2: 1000 mg of beleric capsule taken QD 40 mg of Febuxostat taken QD Jaffe method, MDRD Study equation, Salbutamol challenge test, Ellman’s method, Chrono-log light transmittance aggregometry, Spectrometry, Colorimetric detection with Griess reagents SCr (pre vs post): group B: 1.86±0.32 vs 1.64±0.29, p≤0.005. Group C: 2.06±0.26 vs 1.56±0.24, p≤0.0001 Yes -11.70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±9.00 (SCr, group B), -24.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±8.14 (SCr, group C). 6 months
    eGFR (pre vs post): group B: 39.13±6.57 vs 45.96±11.14, p≤0.005. Group C: 34.78±5.34 vs 48.93±11.46, p≤0.0001 16.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±14.87 (eGFR, group B), 40.39{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±20.98 (eGFR, group C)
    Serum uric acid (pre vs post): Group B:8.10±0.67 vs 6.46±0.34, p≤0.0001. Group C: 8.54±0.64 vs 5.63±0.37, p≤0.0001 19.84{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±6.43 (serum uric acid, group B), 33.88{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}±4.95 (serum uric acid, group C)
    Naturopathy (n=5)
    Khan et al. (2014) [60] Malnutrition Alpha-keto amino acid tablets TID x 3 months Placebo tablets TID x 3 months Blood tests Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (g/dL) (T vs C): 9.39±0.87 vs 8.91±1.48, p<0.05 Yes 19.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (Hb{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) 3 months
    FBG (mg/dL) (T vs C): 104.00±8.46 vs 113.78±14.31, p<0.001 -20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (FBG)
    Blood urea (mg/dL) (T vs C): 66.07±19.29 vs 79.78±24.79, p<0.001 -38.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (blood urea)
    SCr (mg/dL) (T vs C): 2.83±1.10 vs 3.33±1.37, p<0.05 -39.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (SCr)
    24 h TUP (g/day) (T vs C): 2.06±0.61 vs 2.43±0.97, p<0.01 -38.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUP)
    24 Hour TUV (mL/day) (T vs C): 1943.23±204.1 vs 1736.76±176.04, p<0.001 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (TUV)
    GFR (mL/min) (T vs C): 29.4±3.68 vs 23.3±1.63, p<0.001 49.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (GFR)
    Prakash et al. (2004) [61] Malnutrition Keto amino acid tablets QD x 9 months Placebo tablets QD x 9 months 99mTc-DTPA plasma sample method GFR (mL/min/ 1.73 m2) (pre vs post within C): 28.6±17.6 vs 22.5±15.9, p=0.015. Progress of renal failure prevented. 9 months
    Serum total proteins (g{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (pre vs post within C): 7.04±0.66 vs 6.56±0.83, p=0.038
    Mid-arm circumference (cm) (pre vs post within C): 28.0±4.4 vs 27.3±4.8, p=0.048
    Sedaghattalab et al. (2021) [62] Inflammation Watercress extract QD x 1 month Placebo extract QD x 1 month Blood tests, TBA reaction assay, Colorimetric kits, Spectrophotometer BUN (mg/dL) (pre vs post): 40.6±11.2 vs 34.6±15.1, p<0.04. Yes -14.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (BUN) 1 month
    Calcium (mg/dL) (pre vs post): 8.8±1.32 vs 10.4±2, p<0.001 18.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (calcium)
    Total oxidant status (μM) (pre vs post): 11.3±3.3 vs 6.9±2.4, p<0.001 -38.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (total oxidant status)
    Sulfhydryl protein (mmol/L) (pre vs post): 13.1±5.3 vs 7.4±4.3, p<0.001 -43.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (sulfhydryl protein)
    MDA (mmol/L) (pre vs post): 1.6±0.13 vs 0.42±0.27, p<0.001 -73.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (MDA)
    Superoxide dismutase (U/mL) (pre vs post): 29.3±6.3 vs 37.1±8.4, p<0.001 26.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (superoxide dismutase)
    Zare et al. (2019) [63] Inflammation Garlic extract tablets TIW x 2 months Placebo tablets TIW x 2 months Human homocysteine kits, ELISA IL-6 (pg/mL) (pre vs post): 2.2 (0.8, 6.4) vs 0.7 (0.6, 1.2), p<0.001 Yes -68.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6) 2 months
    CRP (mg/L) (pre vs post): 13.0 (5.0, 14.0) vs 2.0 (1.0, 9.0), p<0.001 -84.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (CRP)
    ESR (mm) (pre vs post): 50.7±28.5 vs 35.4±21.7, p=0.021. -30.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (ESR)
    Boldaji et al. (2019) [59] Hypertension, stress, and inflammation Pomegranate juice TIW x 2 months Routine care Mini nutritional assessment MDA (μmol L-1) (pre vs post): 0.88±0.01vs 0.77±0.01, p<0.001 Yes -12.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (MDA) 2 months
    Total antioxidant capacity (mmol L-1) (pre vs post): 0.40±0.08vs 0.49±0.11, p<0.001 22.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (total antioxidant capacity)
    IL-6 (ng L-1) (pre vs post): 3.00±1.48 vs 2.09±1.25, p<0.0001 -30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (IL-6)
    Homeopathy (n=2)
    Cavalcanti et al. (2003) [16] Uremic pruritus Homeopathic verum medicationd administered Placebo medication administered Validated scale Pruritus score (pre vs 15 vs 30 vs 45 vs 60 days): 65±25 vs 46±29, p=0.002 vs 41±30, p=0.002 vs 42±29, p=0.002 vs 38±33, p=0.004 Yes -29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 15 days), -36.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 30 days), -35.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 45 days), -41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (pruritus score, pre vs 60 days) 60 days
    Silveira et al. (2019) [64] Renal function Brazilian green propolis pills BID x 3 months Placebo pills BID x 3 months Immunoturbidimetry, ELISA Proteinuria (mg/24 h) (T vs C, baseline vs 12 months): 695 (95{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} CI, 483 to 999) vs. 1403 (95{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} CI, 1031 to 1909); p=0.004 Yes -27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} (proteinuria) 12 months

    Tools used for outcomes assessments of symptoms during interventions are as follows: the most frequently utilized tools were the abbreviated version of the World Health Organization Quality of Life-100 Questionnaire (n=2) and visual analog scale (n=2).

    Risk of bias within studies: Out of all included studies, 14 (42.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) studies were assessed to be of “low” risk of bias, nine (27.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and 10 (30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) studies were scored as “some concerns” and “high” risk of bias, respectively.

    Results of Individual Studies

    Traditional Chinese medicine: The most commonly utilized interventions in the studies were herbal treatments (n=14, 70{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17, 37-43, 45-49, 51, 52] followed by acupuncture (n=6, 30{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [3,7,36,38,44,50]. For acupuncture treatment, five studies used conventional acupuncture [3,7,36,38,50] while one study used infrared stimulation of acupoints [44]. The common acupoints administered during conventional acupuncture treatment were Li11 (n=3, 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), ST36 (n=2, 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and Li4 (n=2, 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The frequency of acupuncture ranged from once a week to once a day, whereas the duration of studies lasted between six weeks to six months. Uremic pruritus (n=3, 60{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) was the most commonly studied indication, with reductions in pruritus score observed between 54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [7,36,38]. Infrared stimulation was used on RN6, RN4, and RN3 thrice a week for three months [44]. The indication studied was quality of life (QoL). According to QoL scores that were evaluated using the EQ-5D questionnaire, utility increased by 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}.

    Herbal treatments include six single-herb (n=6, 42.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [39-42,48,49,51] and eight multi-herbs formula granules (n=8, 57.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17,37,41,43,45-47,52]. Common single-herb treatments used are Huangkui (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and TWHF (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The frequency of treatment was once to three times a day, for two to 12 months. Proteinuria was the most studied indication (n=4, 66.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), where the various treatments reduced proteinuria between 27.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [39,42,48,51]. Common herbs used in the multi-herb formula granules studies included Huang Qi (n=6, 75{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), Danggui (n=4, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), Salvia miltiorrhiza (n=3, 37.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and Poria (n=3, 37.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). The most commonly studied indication was improvement in renal function (n=5, 62.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [17,41,43,47,52]. Serum creatinine decreased (2.76-12.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and eGFR increased (7.07-15.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) across the various treatments.

    Ayurveda: The included studies evaluated both plant-based (n=3, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53,54,56] and animal-based (n=3, 50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) treatments [55,57,58]. The most common treatment studied was plant-based silymarin tablets (n=2, 33.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) while that for clinical indication was improvement in renal function (n=4, 66.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [53-56]. The eGFR increased between 16.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} across the various treatments [53-56].

    Naturopathy: Keto amino acids were the most studied naturopathic treatment (n=2, 40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Common indications studied included anemia and glucose control, where hemoglobin and fasting blood glucose levels in subjects improved by 19.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 20.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, respectively [60,61]. The use of watercress and garlic extract was also studied for inflammation, where the total oxidant status and IL-6 levels were shown to improve by 38.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 68.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, respectively.

    Homeopathy: Homeopathic verum was studied for relief of uremic pruritus with improvement in pruritus score between 29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} and 41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} [16]. For Brazilian green propolis pills, it was studied for proteinuria where a 27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} reduction in proteinuria was noted [64].

    Safety Profile of AMS Interventions

    The adverse events reported by all included studies are shown in Table 3. Adverse events reported were of grade 1 (n=13, 39.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), grade 2 (n=8, 24.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and grade 3 (n=6, 18.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) severity. There were no life-threatening consequences or death related to adverse effects (grades 4 and 5) reported.

    Study (year) N (T) Treatment Reported adverse effects based on Common Terminology Criteria for Adverse Effects (CTCAE) v5.0a,b,c Onset of adverse effects (if available) Management and outcomes of patients
    Grade 1 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Grade 2 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Grade 3 ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Traditional Chinese medicine (n=19)
    Chenet al. (2013) [37] 95 9.6 g of Shenqi particle TID x 48 weeks NI Interstitial pneumonia (n=1, 1.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Lung infection (n=5, 5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); liver injury (n=3, 3.15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Geet al. (2013) [39] 34 40 mg Tripterygium Wilfordii Hook F TID x 3 months Vomiting (n=13, 38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Hyperkalaemia (n=8, 23.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Leukopenia (n=1, 2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Photosensitive dermatitis (n=3, 8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI Patient with decreased white blood cell withdrawn from the study
    Liet al. (2020) [42] 735 Huangkui capsule TID x 12 months NA NA Upper respiratory tract infections (n=21, 2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Zhanget al. (2014) [51] T1:133 T2:136 T1: Huangkui capsule TID x 6 months T2: Huangkui capsule TID and Losartan potassium tablet QD x 6 months  Elevated cholesterol (T1: n=5, 3.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=4, 2.94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Upper respiratory tract infections (T1: n=4, 3.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=4, 2.94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Liver injury (T1: n=3, 2.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Xionget al. (2020) [48] 62 60 mg Tripterygium Wilfordii Hook F and 160 mg valsartan QD x 24 weeks Itchy skin (n=4, 6.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); nausea (n=3.22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); rash (n=1, 1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA Liver dysfunction (n=12, 19.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); leukopenia (n=1, 1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Liet al. (2015) [41] 122 8 g Tangshen Formula granules and angiotensin receptor blockers BID x 24 weeks NA Anaemia (n=2) Acute myocardial infarction (n=5) NI NI
    Maet al. (2013) [43] 25 150 mL zishentongluo solution BID x 3 months NA NA NA NA NA
    Wanget al. (2012) [17] T1:192 T2:191 T1: TCM granules BID x 24 weeks T2: TCM granules BID and 10 mg benazepril QD x 24 weeks Dry cough (T2: n=2, 1.04{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Gastrointestinal symptoms (T1: n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=3, 1.57{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Anaemia (T1: n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=6, 3.14{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) Liver injury (T1: n=2, 1.04{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2: n=5, 2.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); hyperkalaemia (T1 n=7, 3.64{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}; T2 n=18, 9.42{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NI NI
    Yuet al. (2017) [50] 28 Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months Mild pain, bleeding and bruising in some patients  NA NA NI Symptoms resolved spontaneously without any treatment
    Zhaoet al. (2020) [52] 171 Herbal granules TID x 6 months Mild abnormal liver function test (n=5, 2.92{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); Mild discomfort (n=2, 1.17{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA   NI NI
    Xianget al. (2016) [47] 51 QDDHGb tablets BID x 12 weeks Insomnia (n=1, 1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Xuet al. (2016) [49] 91 500 mg GS-Rb1 (ginseng extract) QD x 6 months  NA NA NA NI NI
    Che-yiet al. (2005) [36] 20 Acupuncture at Quchi (L11) acupoint TIW x 1 month Elbow soreness (n=2; 10.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI Symptoms resolved spontaneously after 1 day.
    Gaoet al. (2002) [38] 34 Acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month NA NA NA NA NA
    Nahidiet al. (2018) [7] 15 Acupuncture at various acupoints TIW x 6 weeks NA NA NA NA NA
    Onoet al. (2015) [3] 23 Acupuncture QIW x 2 months NA NA NA NA NA
    Suet al. (2009) [44] 31 Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months NA NA NA NA NA
    Wanget al. (2019) [45] 41 Qingshen granules TID x 3 months NA NA NA NA NA
    Wanget al. (2020) [46] 136 Qingshen granules TID x 3 months NA NA NA NA NA
    Liet al. (2009) [40] 32 Tianbaoning tablets (gingko extract) TID x 8 weeks NA NA NA NA NA
    Ayurveda (n=6)
    Alamet al. (2020) [53] 70 Sativa oil QD and alpha-keto amino acid tablets TID x 3 months NA NA NA NA NA
    Fallahzadehet al. (2012) [54] 30 140 mg silymarin tablet QD x 3 months Nausea and vomiting (n=3, 10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); headache (n=2,6.67{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Hoseiniet al. (2019) [55] 22 Camel milk BID x 3 months NA Abdominal pain (n=1, 4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI NI
    Khajehdehiet al. (2011) [56] 28 140 mg silymarin TID x 3 months NA NA NA NA NA
    Makhlough et al. (2010) [57] 17 0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks NA Severe skin burning (n=1, 2.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NI NI
    Pingaliet al. (2020) [58] 18 1000 mg of beleric capsule taken QD Mild gastrointestinal intolerance (n=2, 11.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NA NA
    Naturopathy (n=5)
    Khanet al. (2014) [60] 80 Alpha-keto amino acid tablets TID x 3 months Nausea (n=5, 6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); diarrhoea (n=5, 6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NA NA
    Prakashet al. (2004) [61] 21 Keto amino acid tablets QD x 9 months NA NA NA NI NI
    Sedaghattalabet al. (2021) [62] 22 Watercress extract QD x 1 month NA NA NA NA NA
    Zareet al. (2019) [63] 19 Garlic extract tablets TIW x 2 months NA NA NA NI NI
    Boldajiet al. (2019) [59] 22 Pomegranate juice TIW x 2 months Stomach discomfort (n=1, 4.54{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) NA NA NI NI
    Homeopathy (n=2)
    Cavalcantiet al. (2003) [16] 11 Homeopathic verum medicationc administered NA NA NA NA NA
    Silveiraet al. (2019) [64] 18 Brazilian green propolis pills BID x 3 months NA NA NA NA NA

    Adverse effects associated with traditional Chinese medicine: the use of acupuncture is associated with mild pain, bleeding, bruising, and elbow soreness (grade 1) [36,40]. These symptoms resolved spontaneously without additional treatment. For single-herb treatments, TWHF treatment was associated with vomiting (38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), itchy skin (6.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), nausea (3.22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1), and rash (1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1) [39,48]. Grade 2 adverse events associated with its use included hyperkalemia (23.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), leukopenia (2.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), and photosensitive dermatitis (8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), while grade 3 adverse effects included liver dysfunction (19.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and severe leukopenia (1.61{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}). Subjects who developed leukopenia were withdrawn from the study.

    For Huangkui treatment, adverse effects observed included elevated cholesterol (2.94-3.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 1), upper respiratory tract infection (2.94-3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 2 and grade 3), and liver injury (2.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) (grade 3) [42,51]. The use of Shenqi particles was associated with interstitial pneumonia (1.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 2), lung infection (5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 3), and liver injury (3.15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 3) [37]. Anemia (grade 2) and acute myocardial infarction (grade 3) were observed for subjects using Tangshen formula granules [41]. The use of QDDHG tablets was associated with insomnia (1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 1) [47].

    Adverse effects associated with ayurveda: Silymarin treatment was associated with nausea and vomiting (10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}), as well as headache (6.67{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [54,56]. Beleric capsule treatment was associated with mild gastrointestinal intolerance (11.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) [58]. Adverse effects from both studies were of grade 1 severity. Abdominal pain (4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, grade 2) was observed with the treatment of camel milk [55].

    Adverse effects associated with naturopathy: All adverse effects reported for naturopathy treatments are of grade 1 severity (Table 3). They include nausea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) and diarrhea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) with the use of alpha-keto amino acid [60], as well as stomach discomfort (4.54{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) with the use of pomegranate juice [59].

    Adverse effects associated with homeopathy: No adverse effects were reported with the use of homeopathy (Table 3).

    Summary of Efficacy and Safety Profile of AMS Interventions

    Table 4 shows a summary related to the efficacy and safety profiles of AMS interventions.

    Type of AMS Common doses and treatment regimens and duration of therapy Indications Percentage reduction in CKD symptoms (if available) Adverse effects reported ({fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    TCM (n=20) [3,7,17,36-52] Herbal Renal function 2.76{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 51.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Elbow soreness (10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); liver injury and dysfunction (1.04-19.40{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); dry cough, pneumonia, and upper respiratory infections (1.04-5.26{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); hyperkalemia (3.64-23.50{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); vomiting (38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); leukopenia and anemia (1.61-2.90{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); photosensitive dermatitis, itchy skin, and rash (1.65-8.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); gastrointestinal symptoms, nausea, and vomiting (1.57-38.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); insomnia (1.96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Herbal granules TID x 6 months; QDDHG tabletsa BID x 12 weeks; 500 mg GS-Rb1 QD x 6 months; 8 g TSF granules and ARB BID x 24 weeks; 150 mL ZSTL solution BID x 3 months; TCM granules BID x 24 weeks
    Acupuncture
    Acupuncture at Li4, ST36 and K13 acupoint QD x 3 months
    Herbal Proteinuria -61.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -18.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    9.6 g of Shenqi particle TID x 48 weeks; 40 mg TWHF TID x 3 months followed by 20 mg TWHF TID x 3 months; Huangkui capsule TID x 12 months; 60 mg TWHF and 160 mg valsartan QD x 24 weeks
    Acupuncture Uremic pruritus -60.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -54.7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Acupuncture at Quchi (L11) acupoint TIW x 1 month; acupuncture at Quchi (L11) and Zusanli (ST 36) acupoint BIW x 1 month; acupuncture at various acupoints TIW x 6 weeks
    Acupuncture QIW x 2 months Fatigue, insomnia, itchiness, and pain -89.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 15.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Infrared stimulation of Qihai (RN6), Kuamyuan (RN4) and Chungchi (RN3) TIW x 3 months QoL -9.10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 163{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Qingshen granules TID x 3 months Wnt/β-catenin signaling pathway -61.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 17.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Qingshen granules TID x 3 months Immune function 42.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -20.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    TBN tablets (gingko extract) TI x 8 weeks Vascular endothelial function 44.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 40.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Ayurveda (n=6) [53-58] Plant-based Renal function -56.0{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 86.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Nausea, vomiting, and headache (6.67-10{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); abdominal pain (4.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) severe skin burning (2.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Sativa oil QD and alpha-keto amino acid tablets TID; 140 mg silymarin TID x 3 months; 140 mg silymarin tablet QD x 3 months
    Animal-based
    Camel milk BID x 3 months
    0.03{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} capsaicin ointment QID x 4 weeks Uremic pruritus -84.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    1000/500 mg of beleric capsule taken QD Hyperuricemia -24.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 40.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Naturopathy (n=5) [59-63] Alpha-keto amino acid tablets TID x 3 months; Keto amino acid tablets QD x 9 months Malnutrition 39.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 49.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} Nausea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); diarrhea (6.25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}); stomach discomfort (4.45{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c})
    Watercress extract QD x 1 month; garlic extract tablets TIW x 2 months Inflammation -73.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 26.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Pomegranate juice TIW x 2 months Hypertension, stress, and inflammation -30.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to 22.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Homeopathy (n=2) [16,64] Homeopathic verum medicationb administered x 60 days; Brazilian green propolis pills BD x 3 months Uremic pruritus -41.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} to -29.2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
    Renal function -27.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

    Discussion

    To the best of our knowledge, this is the first review that has summarized findings related to the therapeutic uses of AMS for CKD patients in RCTs. Among the four classes of AMS, TCM was the most studied class which has demonstrated efficacy in improving CKD-related symptoms and outcomes [3,7,36-52]. Among the TCM interventions evaluated, Huangkui, TWHF, and acupuncture have shown efficacy in reducing proteinuria and relieving uremic pruritus symptoms. The therapeutic basis of TCM for CKD is rooted in the restoration of vital energy and nourishment of blood, dispelling of heat and reduction of dampness, and regulation of Yin and Yang in the body [65]. In Western medicine, this is seen in a reduction in inflammation and oxidative stress, as well as boosting micro-circulation and enhancement of metabolism [52]. For example, Huangkui, also known as Abelmoschus manihot, reduces proteinuria by removing oxygen radicals, improving the circulation, and clearance of immune complexes as well as reducing inflammation and renal tubular epithelial injury [66]. It is also noted that triptolide, the key constituent of TWHF, suppresses the nuclear factor kappa b (NF-κB) signaling pathway and prevents the trigger of T lymphocytes and some inflammatory cytokines (TNF-α, IL-1β, IL-6, and IFN-γ), in addition to its podocyte-protective capabilities [67-70]. Notably, two of the included studies demonstrated that a combination of TCM and Western medicine, such as the intake of Huangkui capsule and losartan tablet to alleviate proteinuria, is more efficacious than taking TCM or Western medicine alone. This adds to existing evidence on potential applications of TCM alongside conventional medical therapy. Among patients on TWHF, regular checks of potassium and liver enzymes should be performed due to the risk of hyperkalemia and raised liver enzymes.

    With regards to the use of acupuncture, it results in the release of endogenous opiate-like substances that have been proposed to dull the peripheral and central perception of itching [71]. Stimulation of acupoints via far infrared (FIR) treatments has also been revealed to boost skin microcirculation, lessen emotional anxiety and promote excretion of waste products by improving the autonomic nervous system [44,72-76]. Enhanced circulation via a stronger autonomic nervous system is postulated to relieve CKD-related symptoms as the development of renal failure is attributed to poor circulation in the field of TCM [73,77]. Currently, renowned hospitals in the United States such as the Mayo Clinic and Duke University Medical Center have started providing acupuncture, along with other treatments. With growing evidence related to the efficacy and safety of TCM, there has been greater receptivity from medical doctors related to applications and use of TCM in clinical practice [78]. It is however important to note that TCM is not without any side effects. For example, the use of Huangkui should be cautioned in patients with hyperlipidemia or liver disease as its use has been associated with elevated lipid levels and liver injury. On the other hand, acupuncture appears to be relatively safe with mild side effects, such as elbow soreness. More studies related to TCM are required to further assess their long-term safety profile, and they should be prescribed with careful consideration of each patient’s health condition.

    For Ayurveda, silymarin was one of the most studied interventions which demonstrated efficacy in improving renal function. Ayurvedic therapies are derived predominantly from plants, animals, minerals, exercise, and lifestyle changes. They are believed to rejuvenate and remove toxins from one’s body. In conventional medicine, the therapeutic effects of ayurveda for CKD are ascribed to their anti-inflammatory and anti-oxidant properties. For instance, silymarin has shown efficacy in in vitro studies in attenuating inflammatory stress in renal tissue by suppressing the NF-κB signaling pathway and hence TNF production [79-85]. Other Ayurvedic treatments, such as the application of capsaicin ointment, were also found to alleviate uremic pruritus. Topical capsaicin, a natural alkaloid derived from red chili pepper, has been discovered to relieve uremic pruritus by binding specifically to type C sensory neurons and resulting in the release of substance P, as well as suppressing its synthesis, transport, and storage thereafter [57]. Relatively few side effects were observed for the Ayurvedic therapies discussed above. Despite the promising benefits associated with Ayurvedic treatments, it is currently less globally recognized as compared to TCM [86]. Further research is necessary to evaluate their efficacy and safety profile to improve their acceptance in clinical practice as adjunctive treatments, in particular for CKD patients.

    For naturopathy, its unique attribute lies in the reprioritization of the order of therapeutics, with increased emphasis on non-invasive treatments, such as lifestyle modifications and nutrition, over medical or surgical interventions. In this review, one of the more studied interventions is the use of ketoanalogues of essential amino acids (KAs). The addition of KAs to a low-protein diet has been shown to improve renal function and uremia. Notably, while lowering protein intake may improve renal function in CKD patients by altering immunologic events and reducing hypertrophy and hyperfiltration in the remaining nephrons, it may result in malnutrition [87-89]. However, the supplementation of KAs not only averts malnutrition by ensuring adequate consumption of amino acids but also alleviates uremia [61]. The absence of amino nitrogen in KAs allows them to become transaminated by taking nitrogen from non-essential amino acids and hence, reducing the production of urea via re-using the amino group [90,91]. Relatively few and mild adverse effects were observed for the included naturopathic therapies, rendering them attractive treatment options. Additionally, as naturopathic treatments are usually non-invasive, they can be easily combined with conventional medications. Of note, 28 health systems, hospitals, and cancer treatment centers in the United States currently have at least one licensed naturopathic physician at their premises [92]. With increasing research evaluating the efficacy and safety profile of naturopathic treatments, its role as potential adjunctive treatment for CKD patients is also likely to expand in the future.

    Lastly, homeopathy has also shown efficacy in improving CKD-related symptoms and outcomes. Homeopathy entails the therapeutic administration of substances derived from plants, minerals, or animals which produce effects that correspond to the clinical manifestation of diseases. In this review, the use of Brazilian green propolis pills and homeopathic verum medication were found to improve renal function and alleviate uremic pruritus, respectively. Brazilian green propolis was reported to improve renal function via a few mechanisms. Firstly, it decreases proteinuria via its ability to reduce urinary oxidative stress and macrophage infiltration into the kidneys [93]. Secondly, chrysin, a flavonoid in propolis has been shown to decrease podocyte apoptosis in patients with diabetic nephropathy and lessen glomerular injury [94]. Lastly, propolis has also been shown to decrease blood pressure via acetylcholine-induced vasodilation and from its antioxidant properties [93,95-97]. With regard to the safety of homeopathic treatment, no adverse effects were reported across included studies. However, the practice of homeopathy is relatively restricted, with 36{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of states in the United States requiring homeopathic practitioners to either be licensed Western medicine or Naturopathic practitioners [32]. Consequently, more research is necessitated to validate the efficacy and safety of homeopathic treatment as adjunctive therapy for CKD patients.

    Limitations

    The following limitations should be considered in conjunction with this review. Firstly, due to the clinical and methodological heterogeneity of the studies, meta-analyses were not performed. As the pool of evidence for AMS trials for CKD patients grows, subsequent reviews should consider conducting meta-analyses for the efficacy of AMS treatments for CKD patients. In addition, there could have been exclusion of potentially applicable studies even though an extensive search strategy was used. To prevent this, the references of included studies were also hand-searched as part of our search strategy. Another limitation of the study relates to the inclusion of only articles in English language. Researchers should consider the inclusion of studies in other languages such as Chinese and Tamil in future reviews. Finally, although results of the included studies were reported normalized Z scores, care should be taken when interpreting these values and comparing the efficacy of various AMS classes. This is due to considerable diversity in types of outcomes evaluated and comparator arms and tools adopted for evaluation of outcomes. Overall, it is hoped that with greater standardization of study outcomes for AMS therapies in future studies, these normalized Z scores can enable more purposeful comparisons of the efficacy of the different AMS classes.

  • Longview Regional Medical Center celebrates year of accomplishments | Local News

    Longview Regional Medical Center celebrates year of accomplishments | Local News

    Longview Regional Healthcare Centre officers say three places aided shape its “successful” 2022: group involvement, clinical achievements and recognitions.

    “Our group is definitely fortuitous to have this resilient and committed team of clinicians and caregivers right here in the Gregg County location who make a variation for so a lot of individuals every single day,” said Steve Gordon, CEO of Longview Regional. “We helped persons get well and dwell more healthy, and that was obvious in so numerous ways — patients still left with less soreness next a joint replacement, a coronary heart beating stronger after going through an advanced life-conserving cardiac course of action or a smile of reduction when their screening mammogram or colonoscopy was apparent.” 

    Neighborhood

    In January 2022, Longview Regional acquired the Healthcare Hero Award from the Longview Chamber of Commerce for demonstrating management, fortitude, dedication and love for the group all through the COVID-19 pandemic.

    Longview Regional also held its eighth yearly heart screening function, screening far more than 2,500 East Texas teenager hearts for free. The clinic partners with the Championship Hearts Basis, a Texas nonprofit agency, to host the screenings.

    All place students who take part in athletics, cheerleading, marching band, drill group or other athletics are inspired to get their heart screened for achievable lethal genetic coronary heart situations, such as hypertrophic cardiomyopathy.

    “Hypertrophic cardiomyopathy is a genetic heart affliction that typically does not impair physical exercise, but it can have an enhanced risk for a most likely lethal rhythm trouble that could happen proper on the playing industry,” Regional Clinics cardiologist Dr. Jonathan Greifenkamp reported. “HCM can be complicated to diagnose throughout a bodily assessment, but is extremely simply detected with an echocardiogram.”

    The totally free celebration screenings are designed doable in part by the cost-free use of services and devices at Longview Regional and the volunteer time of the hospital’s cardiologists and staff.

    More than 17,000 students have been screened by Championship Hearts Basis in the course of the very last decade, with about 5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of individuals having been referred for even further cardiac screening.

    Longview Regional in 2022 also resumed its annual NICU Reunion right after a two-year hiatus brought on by COVID-19 limitations. This earlier year’s NICU Reunion was a Halloween-themed event held at The Summit Club.

    NICU graduates from 2013-2022 ended up invited to celebrate and check out with the healthcare facility group.

    “We generally take pleasure in browsing and observing our NICU graduates and families. It is really a special time of reconnecting and celebration,” mentioned Kelly Chambliss, maternal youngster director at Longview Regional. “It’s an honor to be a part of each child’s journey. We look at every child a aspect of our LRMC family members.”

    In Oct, Longview Regional held a neighborhood trunk or address party that drew more than 1,000 attendees.

    “Longview Regional Health care Center was very pleased to provide the community an possibility for young ones to properly do some trick or managing and to join jointly for a entertaining occasion,” reported Libby Bryson, Longview Regional internet marketing director.

    Also in Oct, in honor of Breast Cancer Recognition Thirty day period, The Middle for Breast Care of Longview Regional provided discounted mammograms.

    And Longview Regional Healthcare Centre has joined the new GLOW (Higher Longview Optimum Wellness) initiative aimed to boost Longview-area residents’ access to well being and wellness services.

    Clinical

    In February, The Heart and Vascular Institute of Longview Regional’s Structural Coronary heart and Valve Team celebrated the completion of 400 minimally invasive Transcatheter Aortic Valve Substitution (TAVR) processes.

    TAVR is an option treatment choice for people with symptomatic aortic valve stenosis, including these sufferers who are not candidates for open up-coronary heart valve medical procedures.

    “This milestone is considerable to the community for many good reasons. 1 of notoriety is the volume-final result marriage that is regarded in a lot of cardiovascular medical procedures scientific studies these types of as the New England Journal of Medicine that concluded a facility that has a higher procedural volume is instantly correlated to very low mortality costs in cardiac hospitals,” stated Dr. Samir Germanwala, Longview Regional interventional cardiologist.

    “The Coronary heart and Vascular Institute of Longview Regional has a mortality charge that is considerably decrease than the countrywide normal and which even further supports that Longview Regional is an excellent facility to acquire your heart treatment,” Germanwala explained.

    TAVR is a technique that will allow specifically properly trained teams to change a diseased aortic coronary heart valve without open up-heart medical procedures. The procedure removes the want for the coronary heart-lung machine and does not have to have stopping the heart.

    The childbirth crew at Longview Regional now is working with an artificial intelligence-primarily based maternal-fetal early warning procedure termed PeriWatch Vigilance to increase client safety during labor and delivery.

    The process repeatedly displays maternal vital indicators, fetal coronary heart rate, contractions and labor progression to help clinicians quickly identify any concerning developments for more rapidly intervention.

    Longview Regional delivers a lot more than 2,000 babies just about every yr.

    Dr. Charles Newlin, main of Longview Regional OB/GYN, stated the new technology is an vital resource to aid maternal/fetal well being and safe deliveries.

    “Every shipping and delivery is special, so the overall health and well-getting of each individual mother and newborn is our precedence through childbirth,” stated Dr. Sabrina Benefield. “While most births come about without complication, there are some inherent risks in the delivery of a new child. This new know-how provides a further layer of defense all through the labor process to help our maternity group identify, prevent and react to avoidable issues.”

    Through sample recognition, the know-how can also pinpoint alternatives for overall advancement dependent on consolidated knowledge from multiple births, according to Longview Regional. As the maternity workforce testimonials trends and identifies areas in which improvement is possible, the clinic can use that facts to produce protocols that more raise basic safety and may possibly guide to greater outcomes for moms and infants.

    Longview Regional in 2022 also celebrated its 100th remaining atrial appendage closure (LAAC) implant, which decreases the possibility of stroke for clients with persistent atrial fibrillation (Afib).

    Individuals with atrial fibrillation, which consequences approximately 3 million Individuals, are at enhanced risk of stroke thanks to the possible of clots forming in the left atrial appendage.

    “This milestone is a testomony to the Heart and Vascular Team’s motivation to our sufferers. We strive to have entry to the most advanced cardiac everyday living saving therapies to treat Afib,” reported electrophysiologist Dr. Jorge Massare.

    The gadget functions by closing off an location of the heart termed the left atrial appendage closure to preserve hazardous blood clots that can type from moving into the bloodstream and perhaps creating a stroke, according to Longview Regional. 

    in 2022, Longview Regional’s neonatal intensive treatment device been given a donation from the American Coronary heart Affiliation of far more than 100 CPR Anytime kits, which consist of 20 minutes of education for mothers and fathers, grandparents, babysitters and other folks about how to conduct the approach on infants.

    The kits are usually utilized in hospital labor and shipping plans, which includes NICUs, to teach the competencies to individuals who do not need a study course completion card, in accordance to the American Heart Association

    Longview Regional’s Women’s Providers team also resumed Childbirth Training Courses for Expecting Family members in the fourth quarter of 2022. These lessons make it possible for the prospect for new parents to acquire insight and education and learning as they begin a new chapter of everyday living.

    Recognition

    Longview Regional received an “A” Leapfrog Clinic Protection Quality for spring 2022. This countrywide difference acknowledges the hospital’s achievements in protecting sufferers from preventable damage and error.

    “An ‘A’ protection quality is a incredible achievement and a symbol of our commitment to the care and security of the East Texas neighborhood we are so proud to provide,” explained Gordon, the hospital’s CEO. “I would like to thank and recognize Longview Regional’s crew for their motivation to prioritizing people and their well getting. We strive for excellence and compassionate treatment in anything we do. Our each day aim on evidence-primarily based apply and patient-centric care supports our supply of higher excellent and economical treatment to all of our individuals.”

    The Leapfrog Team, an unbiased nationwide watchdog organization, assigns an “A,” “B,” “C,” “D,” or “F” quality to standard hospitals across the state based mostly on above 30 national general performance measures reflecting mistakes, accidents, accidents and infections, as perfectly as units hospitals have in location to reduce damage.

    And Longview Regional was voted Very best Medical center and Ideal Location to Have A Infant in the Longview Information-Journal’s 2022 Finest of East Texas Awards.

    “This is a great honor, and it was made attainable by the teamwork and excellence that our staff deliver every single working day to treatment for our group,” the clinic mentioned in a statement.

  • Endometriosis Hip Pain: Nerve Symptoms and Relief

    Endometriosis Hip Pain: Nerve Symptoms and Relief

    As endometrial lesions (implants) from endometriosis (endo) grow and bleed, they cause inflammation and pain. The nerves around the implant can get entrapped, inflamed, or irritated. When endo affects nerves in the pelvis (between the hips), it can cause discomfort and hip pain.

    This article reviews how endometriosis affects the nerves and causes hip pain, the timing of hip pain throughout the menstrual cycle, and tips for pain relief from endometriosis. 

    SDI Productions / Getty Images


    Endometriosis, Nerves, and Hip Pain

    Endometriosis frequently causes chronic pelvic pain and increased menstrual cramps. It can also affect the nerves in the pelvis and cause leg or hip pain. 

    The pelvis contains complex nerves, including the following:

    • Sciatic  (largest nerve in the body; runs from the lower spine and down the back of each leg)
    • Obturator (a major peripheral nerve in your thigh; responsible for some leg movements and sensation) 
    • Femoral (one of the largest leg nerves; runs from your pelvis down the front of your leg)
    • Pudendal (the main nerve in the area between the anus and genitalia)

    When these nerves become inflamed, damaged, or irritated, they can cause neuropathic pain. This pain can feel sharp or stabbing and radiate (move or spread). Nerve damage or irritation can also cause neuropathy, resulting in numbness or tingling, muscle spasms, and weakness.

    Hip pain from endometriosis can start in your back or pelvis and radiate to your hip, buttocks, or legs. You may feel pain, tingling (pins and needles), or numbness. The location of the pain depends on which nerves are affected.

    Upregulated Nervous System Function

    Upregulation of the nervous system is when something creates a pain signal that travels up the branch of the nervous system. This means it travels from the nerve to the spine and brain. 

    Endometriosis lesions entrap, inflame, or irritate the nerves in the pelvis, sending pain signals to the brain. Endo also triggers nerve growth where they do not typically grow. 

    These factors cause the nervous system, including the brain and spinal cord, to become hypersensitive.

    Cytokines and Prostaglandins

    Cytokines and prostaglandins are substances that are naturally produced in the body as described below:

    • Cytokines are part of the immune system that cause inflammation when trying to kill a bacterium or virus. 
    • Prostaglandins are fatty acids that have hormone-like effects. They are responsible for triggering muscles in the uterus to contract during your period. High levels of prostaglandins cause severe cramps. 

    When a condition such as endometriosis causes increased production of cytokines or prostaglandins, it negatively affects the nervous system. Increased levels activate nerve fibers and trigger nearby cells to release inflammatory molecules. 

    Related Gynecologic Causes

    Some people with endometriosis never experience pelvic or menstrual cramping. Hip pain may be their first and only symptom. In this case, it’s easy to dismiss it and assume it’s a non-gynecologic cause, such as an injury, arthritis, or bursitis. This is especially true when you have not received an endo diagnosis. 

    Endometriosis vs. Bursitis

    Bursitis is inflammation of the bursae (small sacs that cushion the joints) that causes intense joint pain. It occurs due to overuse, repetitive motion, injury, spine conditions, and bone spurs. The pain often gets worse at night and radiates down the thigh. It is intense or sharp at first but dulls or goes away over time. 

    Endometriosis hip pain may be constant or come and go based on your menstrual cycle. However, it doesn’t usually dull or go away with time.

    Several gynecologic conditions, including endometriosis, can cause hip pain. These conditions inflame, entrap, press against, or irritate the nerves, joints, or tissues in the pelvis area. Examples include: 

    Adenomyosis

    Adenomyosis is a gynecologic condition similar to endometriosis. However, the misplaced endometrial tissue stays within the uterus as it spreads to the myometrium (uterus muscles). It also causes heavy menstrual bleeding, painful periods, and hip pain. 

    Timing of Hip Pain From Endometriosis

    Due to changing estrogen levels throughout your menstrual cycle, hip pain from endometriosis may vary throughout the month. The changing levels stimulate the endometrial implants causing them to bleed, resulting in inflammation, irritation, and pain. 

    Ovulation

    Ovulation is the release of an egg from an ovary. It usually occurs mid-cycle, about two weeks before starting your period. It is common to have mild discomfort during ovulation, but it usually goes away after a couple of days. Ovulation pain is generally on one side.

    Endometriosis pain during ovulation can spread to the hips or legs. It usually lasts longer than 48 hours and can cause nausea, vomiting, or diarrhea. 

    Before and During Period

    Endometriosis hip pain often starts a few days before starting your period, gets worse during your period, and stops once the bleeding is over.

    Chronic Issues

    Chronic symptoms are those that last longer than six months. Chronic pelvic pain is one of the most common problems of endometriosis. 

    Research has linked other chronic health concerns to endometriosis. While the exact reasons for these connections are still unclear, they include the following:

    After Hysterectomy

    A hysterectomy is the surgical removal of the uterus and sometimes the ovaries. It is the last resort when treating endometriosis, especially for those who want to conceive more children. 

    Endometriosis symptoms can still occur after a hysterectomy. Most likely because of lesions that were overlooked or left behind. Sometimes lesions do not look like a typical endometriosis lesion or are not located within the surgical area explored. 

    Tips for Endometriosis Hip Pain Relief

    For mild endometriosis hip pain, you can try the following options at home:

    • Change positions: Sometimes, changing positions can help take pressure off the nerve. 
    • Exercise: Movement reduces inflammation, relaxes the muscles, and circulates more oxygen. Exercise also stimulates serotonin and endorphins (mood-elevating chemicals and natural pain relievers). Good options include swimming, walking, stretching, yoga, and pilates. 
    • Cold therapy: Cold packs or a cool cloth can help decrease inflammation. You can apply them to the inflamed area or lower back for 15 minutes several times per day. 
    • Topical medications: You can place topical (on the skin) patches, gels, or creams over sore or inflamed areas and the lower back. They help decrease inflammation, and some also include lidocaine which helps numb the area. Examples include Aspercreme (trolamine salicylate), Bengay (menthol, camphor, or methyl salicylate), Icy Hot (methyl salicylate-menthol), and more.
    • Over-the-counter (OTC) pain relievers: If approved by your healthcare provider, you can try a pain relievers such as Tylenol (acetaminophen) or nonsteroidal anti-inflammatory drug (NSAID) such as Advil or Motrin (ibuprofen) or Aleve (naproxen).
    • TENS machine: Transcutaneous electrical nerve stimulation (TENS) machines are devices that use mild electrical impulses to relieve pain and can be purchased over the counter. 

    Talk with your healthcare provider before using heat therapy. While it helps with endometriosis cramping, it could inflame the nerves, leading to increased hip pain. 

    If the pain is moderate, severe, or progressing, your healthcare provider may suggest the following:

    • Prescription anti-inflammatory or pain medications
    • Hormonal therapy
    • Physical therapy
    • Nerve blocks
    • Muscle relaxers
    • Vaginal Valium (diazepam)
    • Injections, such as Chirocaine (levobupivacaine) or Botox, BTXA, Dysport (onabotulinumtoxin-A)
    • Surgery

    Summary 

    While it’s common to assume that hip pain comes from an injury, arthritis, or bursitis, it can also result from multiple gynecologic conditions, including endometriosis. When endometrial lesions entrap, irritate, or inflame pelvic nerves, pain can radiate to the hip, buttocks, and legs.

    Hip pain due to endometriosis can vary based on your menstrual cycle. Many note it gets worse before their period but starts to ease up after the bleeding is over. 

    In addition to chronic pelvic pain, endometriosis has been connected to fibromyalgia, anxiety, autoimmune disorders, asthma, some cancers, and more. Treatment for endometriosis depends on the severity of your symptoms.

    Frequently Asked Questions

    • What if medication doesn’t help endometriosis hip pain?

      Other interventions such as physical therapy, exercise, acupuncture, or cold therapy can help alleviate hip pain. Surgery may be a consideration when you and your healthcare providers have exhausted all other treatment options, including lifestyle modifications, stretching exercises, medication, and alternative therapies.

    • How do you relax your hip flexors from endo muscle tightening?

      Stretching exercises can help relax your hip flexors. There are several to choose from, including a simple hip flexor stretch or the piriformis stretch. A physical therapist is a great resource to help you decide which is best for you. 

    • How do you know if you have pain from endo or an ovarian cyst?

      Pain from ovarian cysts is usually in the lower abdomen on one side of the body. While it can be a dull ache, it can also cause sudden sharp pain. Endometriosis pain is usually a more generalized (all over) abdominal cramping, like period cramps.